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ABSTRACT 
Poly(ethylene oxide} has some unique solubility and hydrogen-bonding 
characteristics which have been used to explain its apparent inertness with 
regard to blood protein adsorption and platelet interactions. A method has been 
developed to immobilize long chains of this hydrophilic and amorphous polymer 
by derivatization of the end hydroxyl groups allowing attachment to and 
extension out from the surface. This creates an "excluded volume" which is 
inaccessi.ble to large protein molecules and cells. 
Four derivatives of poly(ethylene oxide} (PEO) have been synthesized: 
PEO-bis isocyanate, PEO-bis isothiocyanate, PEO-bis chloroform ate, and PEO-
bis thiochloroformate. The cyanate derivatives were synthesized using the 
lithium salt of cysteamine to form diamine-terminated PEO chains which were 
subsequently reacted with phosgene or thiophosgene. The chloroform ate 
derivatives were produced by directly reacting the hydroxyl groups of the PEO 
with phosgene and thiophosgene. Molecular weights of PEO ranging from 1,000 
to 18,000 daltons were used. 
Heparin was immobilized onto the reactive free ends of these PEO 
derivatives via the free amine and hydroxyl groups of the heparin molecule, 
permitting extension of the anticoagulant from the surface, allowing it to 
assume its native and active conformation for interaction with specific blood 
proteins. 
Surfaces prepared by this method were characterized by X-ray 
photoelectron spectroscopy and found to be stable in aqueous environments. 
Minimal nonspecific protein adsorption and adhesion of platelets to the PEO 
surfaces without heparin was demonstrated by Total Internal Reflection 
Fluorescenne Spectroscopy (TIRF) and 125-iodine labeled proteins. It was found 
that there is a small inverse relationship between chain length of the PEO and 
the quantity of protein adsorbed onto the surface, confirming earlier reports. 
Platelet retention has been studied by exposing platelet rich plasma to 
derivatized glass beads and has demonstrated significantly less retention than 
the control surfaces. 
Quantitation was accomplished using tritiated heparin. The activity of the 
heparin was shown by the ability of these surfaces to bind antithrombin-m and 
by significantly increased whole blood clotting times and activated partial 
thromboplastin times. 
The results reported here suggest that long chain poly(ethylene oxide} 
offers a relatively inert surface for the immobilization of biologically active 
molecules, minimizing nonspecific interactions and providing a mechanism for 
these active molecules to react freely, mimicking their solution activities. 
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1.1 Perspectives on Biocompatibility and Rationale 
Among the various kinds of interfacial phenomena in the field of 
biomaterials chemistry, the adsorption of biomolecules at the interface between 
a liquid and solid phase is one of the most significant areas to be first studied. 
This adsorption influences subsequent biochemical or biological phenomena such 
as platelet or leukocyte adhesion, thrombus formation, and local tissue or 
systemic reactions. 
Compatibility of a material with blood requires no adverse effect on blood 
or any of its components. The complex nature of blood, with its formed 
elements, coagulation system, and multitude of proteins, puts not only a variety 
of restrictions on the blood contacting surface, but also makes the determination 
of blood compatibility a significant problem. The reverse requirement is also 
true: that the blood have no adverse or incapacitating effect on the material. 
A systematic approach to the development of safe and suitable implant 
materials for human use requires: I} matching of the engineering properties of 
the material and the finished devices with those of the corresponding human 
tissues; Z) knowledge of the properties of the implant materials which might 
exert an effect on the biological system; and 3) an understanding of the 
properties of the biological environment which might have an effect on the 
material. Following the development of materials intended for biological 
purposes, extensive testing for the complex interactions must be completed. It 
2 
is surprising that there is incomplete agreement on how these materials are to be 
standardized in terms of chemical, physical, mechanical or biological properties 
in order to determine their relative biocompatability with human tissues, the 
lack of hazardous side effects on the human patient, or their effectiveness as 
reconstruction materials. 
Various recommendations have recently been published in an attempt to 
standardize blood testing protocols and to provide appropriate statistical 
verification for claims of improved "blood compatibility." Unfortunately, it has 
been demonstrated that in-vivo results of implanted polymers do not necessarily 
correlate with the results of in-vitro and ex-vivo testing of biomedical implants. 
P. Didisheim has recommended nine tests for describing compatibility including 
protein adsorption in terms of type and amount, complement activation, cellular 
adhesion, and calcification. (1) J. Anderson has developed several tables listing 
level I and level II type tests describing minimum requirements for 
characterization of new compatible materials. (2) Perhaps the most 
comprehensive testing procedures have been outlined in the recently published 
"Guidelines for Blood Material Interactions" by the National Heart, Lung, and 
Blood Institute. (3) These guidelines offer recommendations for material 
characterization, in-vitro interactions, and testing in appropriate animal models. 
Due to legal, ethical, and religious reasons, our society is not conducive to 
the use of human volunteers for the testing of new biomedical materials. 
Therefore, current techniques for the evaluation of these materials are by nature 
indirect, limited both in accuracy and scope of prediction for human 
applications. Any scientist working in the field of bioengineering must be aware 
of the limitations of both the existing and potential future indirect methods used 
for assessing the biohazards and biocompatibility of new candidate materials. 
3 
It is known that adsorption of proteins is one of the first events when blood 
contacts a foreign surface. (4) Moreover, the nature of the protein layer 
influences subsequent reactions that involve platelets and leukocytes, 
complement activation, and finally, the formation of crosslinked fibrin and 
thrombus. Thrombus formation is by far the most debilitating and obvious 
response to foreign material in contact with the blood. Fig. 1 shows some of the 
major factors which influence the ultimate biocompability and the possible 
course of reactions that may occur. 
Due to the importance of protein adsorption on the fate of a material, this 
area has received the most attention in investigations of the biocompatibility of 
materials. The emphasis in these studies has been on the composition of the 
adsorbed layer, rate of adsorption, and possible changes, such as conformation or 
denaturation over time. This has proven difficult, and most studies have been 
done on solutions of single proteins or simple mixtures. Rates have been 
measured using labels, analysis of the eluted protein, and spectroscopic analysis. 
However, problems have been encountered when applying such measurements to 
the behavior of blood itself. 
In the past, the thrombogenicity of implants has been sufficiently 
overcome by the administration of systemic anticoagulants such as heparin or 
coumadin. However, long term anticoagulation therapy is not advisable due to 
deleterious side effects. For this reason, there have been extensive efforts to 
develop materials which can be used with minimal or no anticoagulation. A 
number of surface parameters have been evaluated in an attempt to correlate 
these properties with the coagulation of blood. Efforts have been made to 
develop new materials, predominately polymeric, which are, by themselves, 
thromboresistant. Comprehensive reviews of individual polymers tested have 
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Figure 1. Factors affecting interfacial phenomena of blood contacting foreign 
surfaces and some of the possible reactions that may occur. 
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polymers, low surface energy materials, hydrogels, urethanes, and biologically 
modified surfaces such as preadsorption of polymers with albumin. The factors 
increasing thromboresistance include increased surface smoothness, increased 
negative surface charge, and increased hydrophilicity. To date no single 
definitive parameter appears to govern the thrombogenic response of the blood 
to the material. 
Surface modification of polymeric materials offers the advantage of 
optimizing the chemical nature of the blood/polymer interface while allowing 
the choice of the substrate to be on the basis of the necessary mechanical 
properties. With this technique, variables such as hydrophilicity and ionic charge 
may be varied without consideration of other stringent requirements on the 
material. An excellent review of the surface modification of polymers to 
improve blood compatibility has been published by Kim and Feijen. (6) 
Early in the development of a thromboresistant material was the finding 
that heparin ionically bound to a surface provides a very significant degree of 
thromboresistance. (7) Since that time, investigators have attempted numerous 
methods to ionic ally and covalently bind anticoagulants onto polymers. Some of 
these attempts have had limited success in clinical use. The problems 
encountered in the ionically bound systems have been depletion of the heparin by 
ion exchange with the blood constituents. In the covalently bound systems, the 
problems have been a decrease or lack of activity of the pharmacon. 
The study presented herein was undertaken to develop a new 
thromboresistant material. In an attempt to identify and develop an optimally 
blood compatible system, a number of desirable qualifications can be listed. The 
ftideal ft polymer would be one which would not initiate the sequence of events in 
any of the coagulation mechanisms, would interact favorably with the cellular 
components, and would not cause tissue reaction or inflammation. If 
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anticoagulation therapy is necessary, emphasis should be placed on developing 
ways to minimize harmful side effects. The material developed during the 
course of this study uses a polymer coating, poly(ethylene oxide), with heparin 
immobilized covalently. 
Poly(ethylene oxide) (PEO) has recently received much attention as a 
potential biomaterial. PEO has some unique properties which have led to its 
consideration for application in implants, oxygenators, dialysis membranes, 
contact lenses, and in immunoassays. Current evidence shows that PEO, either 
by itself or as a component in copolymers, is relatively inert in terms of protein 
adsorption and platelet adhesion. (8,9,10,11,12) The unusual solubility 
characteristics and solution properties of PEO have been used to explain its 
apparent inertness towards blood proteins and platelets. (13) For these reasons, 
PEO was chosen as a good candidate for the development of a biocompatible 
material. 
Heparin is the most frequently prescribed anticoagulant in use today. It is 
a mucopolysaccharide, highly sulfonated, and contains a number of other charged 
functional groups. There are large variations in the individual sugar units and in 
the molecular weight of commercial preparations. Heparin enhances the 
inactivation of thrombin by antithrombin m, thereby inhibiting the fibrinogen to 
fibrin conversion process. Heparin has been used in a variety of ways to increase 
the thromboresistance of polymeric materials. It has been dispersed within a 
matrix and ionically or covalently bound to materials for the purpose of 
improving compatibility. All of these methods have had limited success. 
However, jf heparin can be covalently bound to a surface and still maintain its 
anticoagulant activity, the possibility of depletion of the pharmacon will be 
avoided. This is the approach used in this study. 
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To create a biocompatible surface, long PEO chains were immobilized to a 
surface via a silane coupling agent and heparin molecules were covalently 
attached to the PE~. This provides for a protein resistant surface (the PEO 
chains) and for the local action of heparin. By virtue of the flexibility and 
extension into solution of the PEO chains, the heparin has the freedom to assume 
its native and active conformation. This approach has been tested for its 
stability, protein resistance, and anticoagulant activity. 
1.2 Poly(ethylene Oxide) Background 
1.2.1 Physiochemical Properties 
Poly(ethylene oxide) was first reported by Lourenco in 1860 by the 
condensation of ethylene glycol and ethylene dibromide. (14) With the 
development of the macromolecule concept in the mid-1900s, PEO of high 
molecular weight was one of the first polymers prepared and studied by Herman 
Staudinger. The first synthesis of truly high polymers was announced in 1957. 
PEO was one of the first polymers to be crosslinked by radiation and to have 
inter- versus intramolecular crosslinking delineated in terms of molecular 
weight. (15) The low molecular weight members of the PEO series with n 
(number of repeat units) up to about 150 are generally known as polyethylene 
glycols while the higher members are known as poly(ethylene oxide). 
The two extremes of molecular weight have sufficiently different 
properties as to form two classes. The low molecular weight species range from 
relatively viscous fluids to waxy solids while the higher polymers are true 
thermoplastics. An excellent review of PEO has been published by Bailey and 
Koleske. (16) 
In recent years, PEO and its derivatives have proven valuable in a variety 
of diverse chemical and biological applications. These include peptide synthesis, 
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phase transfer catalysis, pharmaceutical modification, 
purification, polymer-bound reagents and binding assays. 
protein and cell 
The wide range of 
possible applications is due to some very unique properties of PED. 
PEO is soluble in water and a number of organic solvents including 
acetonitrile, chloroform, benzene, and dimethyl formamide. At room 
temperature, it is completely miscible with water in all proportions. The 
extreme water solubility is of particular importance in light of the insolubility in 
water of such closly related polymers as poly(methylene oxide) and 
poly(propylene oxide}. Aqueous solutions of PED are elastic in their behavior and 
the viscosity decreases with increasing shear stress. There is an inverse 
solubility-temperature relationship exhibited by aqueous solutions: as these 
solutions are increased in temperature to near the boiling point of water, the 
polymer precipitates. (17) For very dilute solutions (0.2 percent or less), the 
precipitation is observed as a cloud point. For slightly more concentrated 
solutions (0.5 percent), the polymer precipitates as a gel that slowly shrinks and 
retains the shape of the container on standing at the precipitation temperature. 
This has been explained by the dual nature of the polymer structure 
(Doolittle). (18) There is a hydrophobic character to the polymer due to the 
ethylene units. As a result of bound water molecules, which are presumably 
associated with the ether oxygen, (19) it also exhibits a hydrophilic character. 
Another way to explain the inverse solubility-temperature relationship of PED 
has been suggested by Nemethy as a result of a disordering of bound water or 
nicebergs" that exist about the polymer molecule. (20) These nicebergs" 
correspond to a layer of highly oriented water which would surround the polymer 
in aqueous solution. Increasing the temperature causes a disruption of this water 
and allows relatively strong polymer-polymer interactions, which are mainly 
entropic in nature. 
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The conformations and crystallinity of PEO in the solid, melt and in 
organic and aqueous solutions have been studied. In the absence of crystallinity, 
the amorphous material is a rubber of low glass transition temperature (Tg 
typically -60oC) and exhibits a maximum Tg at molecular weights in the range of 
4000 daltons. Having no chiral centers and no sidegroups, the polymer is 
normally highly crystalline with the melting points up to a theoretical value of 
700 C for infinite molecular weight. (21) The crystalline structure of linear PEO 
has been determined by X-ray diffraction as a 72 helix: seven mer units and two 
turns in a fiber identify period of 19.3 A. (22) Further studies by Miyazawa 
confirmed that the PEO repeating unit is in the trans-gauche-trans (TGT) 
conformation of the COCCOC sequence. (23) Previous work by infrared and NMR 
techniques suggests that the TGT sequence is retained to a large degree in 
aqueous solution. (24) However, Maxfield and Shepard, using Raman scattering, 
found that the ordered nature of the polymer is lost at a critical concentration, 
approximately 50 percent by weight, in both aqueous and chloroform 
solutions. (25) 
While it is more common to study the properties of polymers either in 
solution or as solid materials, many of the practical applications for PEO involve 
its use at or on surfaces. Glass measured the adsorption characteristics of PEO 
at aqueous-air interfaces as a function of polymer molecular weight, 
concentration and temperature. (26) His data indicate that the polymer is 
adsorbed at the interface, for all molecular weights, with portions of the 
polymer chains oriented out of the interfacial region. However, in low molecular 
weight glycols, the terminal hydroxyl groups may have a predominating influence 
and one half of the potentially adsorbed segments are actually oriented in the 
interfacial region. 
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Cosgrove et ale studied the conformation of PEO at the solid/solution 
interface. (27) The conformational behavior of linear, homopolymer PEO 
physisorbed and terminally bonded to polystyrene latex particles was studied by 
these investigators. By using a multipulse NMR relaxation time method which 
reflects both molecular structure and motion, they were able to differentiate 
segments on the chains having different mobility as a function of the method of 
attachment to the surface. In this manner, the ratio of segments in each state 
and the fraction of bound segments may be calculated. It was found that the 
conformation of the polymer chains adsorbed to a surface contains loops and 
trains close to the surface with the long tails extending into solution as 
schematically depicted in Fig. 2. This is for a surface completely covered with 
polymer (i.e., e = 1.0). The effect of degree of coverage was studied and 
segment density distributions could be determined. 
Studies of the characteristics of PEO at aqueous-organic liquid interfaces 
are of considerable interest. PEO in water retains the TGT sequence and helical 
conformation of the crystalline state to a large degree. (28,29) However, in 
organic solvents such as chloroform or benzene, PEO assumes a more random 
conformation. (30) Interfacial pressures of PEO with various molecular weights 
at benzene-water interfaces with PEO initially dissolved in either phase 
demonstrated that equilibrium is attained surprisingly quickly. (17) The 
interfacial tension of dextran - PEO water systems has demonstrated that two 
immiscible water phases are obtained. (31) This has been used as selective and 
mild partitioning systems for separation of various biological materials such as 
proteins, nucleic acids and cell particles. (32) 
PEO is known to form associated complexes with other molecules in 
aqueous solutions. Formation of the association complexes occurs at the expense 
of ordered water associated with the polymer. (33) This disruption of the water 
11 
Figure Z. The possible orientations of poly(ehtylene oxide} chains physically 
adsorbed onto a surface. The long chains may run along the surface, form loops 
and form tails which extend out from the surface. 
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structure provides an added entropic driving force favoring complex formation. 
When aqueous solutions of PEO and poly(acrylic acid) are mixed in approximately 
equal proportions, a precipitate is immediately formed. (34) The formation of 
these insoluble hydrogels is due to the formation of hydrogen bonds between the 
poly-acid and the ether oxygens of the PEO which are weakly basic. 
Evidence exists for the interaction of PEO with metal salts such as 
potassium iodide. This interaction is sufficiently marked such that the 
incorporation of 10-30 percent of the salt in the bulk polymer substantially 
reduces crystallinity while retaining compatibility. (35) No interaction other 
than a very small salting-out effect is observed with potassium iodide and PEO in 
water solution. It has been suggested that the association is due to an ion-dipole 
interaction. The anion is tentatively postulated as the species directly 
associating with the polymer resulting in the concurrent disruption of the 
crystalline structure. (36) Other materials, such as urea and thiourea, have also 
been shown to form associated complexes with PEO, although these are highly 
crystalline complexes. (37) Linear PEO is also able to complex with neutral 
molecular iodine in the solution and solid state to produce 13- ions, 
demonstrating the ability of PEO to mimic the complexation features of the 
macrocyclic crown ethers. (38) 
1.2.2 Theory of the Passivating Nature of PEO 
The behavior of solutions containing globular proteins and PEO has been of 
great interest to protein chemists. The use of PEO to crystalize proteins for 
crystallographic studies is well established (39) and PEO provides an attractive 
alternative to other agents used for protein precipitation. PEO has been used for 
the prevention of macromolecular adsorption (40,41) and for the stabilization of 
colloidal dispersions. (42) 
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The theory developed by Ogston and Laurent and readdressed by 
Topchieva (43) described the exclusion properties of polymers and greatly 
simplified the problem by considering the model of the interaction of a linear 
polymer, represented by a long thin rod, with globular particles which are 
assumed to be spherical (Fig. 3). The greatest exclusion effect is expressed as 
the excluded volume for S, with respect to unit mass of R. The center of the 
spherical particle S cannot approach R to a distance less than rs. The excluded 
volume for the center of S is equal to the volume of the cylinder bounded by 
dashed lines whose radius is equal to the sum of the radii rs + rr (rr = the radius 
of the rod). If the end group effect can be neglected, then the volume excluded 
for the sphere is 1\ lr (rs + rr)2, where lr is the length of the rod. If d is the 
density of the rod, then its mass is ""Ur r2r d, and the excluded volume vexcl 
with respect to unit mass of R is: 
vexcl = '\'\lr(rs + rr)2 = 2.. (~ + 1)2. (1) 
\'tlr r2rd d rr 
The degree of exclusion increases with increasing radius of S and with 
decreasing radius of R or with increasing asymmetry of the polymer. The overall 
volume (Kav) accessible to spheres with radius rs in the space containing 
randomly distributed long rods with radius rr is: 
(2) 
where L is the sum of the lengths of all the rods per unit volume. It can be seen 
that the concentration of the rods and the square of the radius of the spheres are 
the only parameters which determine the accessible volume for the case where 
rr < < rs- The fraction of the volume accessible for a given substance (Kav,) is 
related to the excluded volume by the expression: 
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.. 
Figure 3. Model of the interaction of a linear polymer (cylinder) with a large 
protein molecule (sphere) developed originally by Ogston and Laurent. (44) 
vexcl = (1 = Kav) / CR 
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(3) 
where CR is the concentration of the rods R expressed in terms of mass with 
respect to volume. 
This excluded volume theory was further refined by Knoll and Hermans (44) 
to take into consideration protein size, conformations, and polymer chain 
statistics. The excluded volume (V 12) in this theory is defined similarly as the 
effective volume of a solution that is not available to particles of species 1 as a 
result of the introduction of species 2 strictly for steric reasons. Beginning with 
the expression for this: 
(4) 
where Vx is the average number of particles of species 1 which are excluded 
from the total volume (V tot) by the volume occupied by species 2. The geometry 
of the excluding and excluded species has been taken into consideration for cases 
where the excluding species is either a sphere or a long rod described by a 
cylinder. Conformational freedom of the polymer requires that the excluded 
volume be calculated as an average overall possible conformations of the 
polym er chain. 
The result of the theory is an expression for the excluded volume in terms 
of the root mean square end to end distance of the polymer chain (ho) and the 
radius of the protein, assuming a globular protein and infinitely long randomly 
coiled polymer molecules. Using a probability function for the location of the 
beginning and end of the polymer chains and a Gaussian distribution for the 
number of chain segments, an expression has been derived for the excluded 
volume: (45) 
VIZ = vx/Nl = Vz + (Z/3 )SZho 
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(5) 
where Sz is the surface area of the sphere, Vz is the volume occupied by species 
Z and N is defined as above. Values of ho were estimated from intrinsic 
viscosities; values of protein radii were based upon molecular weight, intrinsic 
viscosity, frictional coefficient and knowledge of molecular conformation. 
Measurement of thermodynamic interaction parameters of bovine serum 
albumin and PED of varying molecular weights using light scattering techniques 
were correlated with theoretical calculations of interactions based on size, 
radius of gyration and solubilities in two solvents. Using this method, these 
investigators were able to predict with relative accuracy the composition and 
distribution of the two phases at equlibrium in terms of thermodynamics and 
statistical mechanics even for dilute solutions in which PED is a poor protein 
precipitating agent. 
Maroudas presented similar evidence for the exclusion of molecules by 
adsorbed polymer as it relates to cell adhesion and membrane fusion. (45) This 
model comprises not only geometric exclusion by rigid molecules, such as rods 
and spheres, but also unfavorable thermodynamic parameters such as free 
energy, summed up over many segments, and for random coil polymers, entropy 
resulting from the ability of each molecule to claim extra extension space for its 
own. This steric exclusion model provides a general physiochemical basis for the 
observation of fusion and for the low adhesivity of neutral hydrophilic gels. 
Another approach explaining the repulsion of two long chain molecules 
(i.e., PED and proteins) has been described by Klein et al. (46) This investigation 
determined the forces as a function of distance, F(D), and the mean refractive 
index n{D), of the medium separating two smooth curved mica surfaces in the 
presence or absence of adsorbed layers of monodispersed PED of two molecular 
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weights. Interactions between bare mica surfaces were characteristic of 
electrostatic double-layer overlap and strongly repulsive as described by DL VO 
theory. Following incubation in PEO polymer solution, no attraction between the 
two layers was detectable as might be expected if bridging or depletion layer 
forces were present. It was determined that the adsorbed PEO was irreversibly 
adsorbed. The distance of onset of repulsive interactions is typically twice the 
extension of the adsorbed polymer layers from the surfaces. In terms of 
unperturbed radii of gyration Rg, the extension from the surfaces is 
approximately 3 Rg for polymers of the two molecular weights. The repulsive 
forces between the mica plates as the adsorbed PEO layers come into overlap 
were attributed to local rise of osmotic interactions between the opposing 
segments. This is to say at the simplest level, that as the surfaces approach, the 
mean concentration of polymer in the overlap region increases with consequent 
increasing repulsion. 
Merrill and Salzman have used the unique solubility and solution properties 
of PEO to explain its favorable interaction with blood proteins when used as a 
biomaterial. (47) These investigators claim that a two-phase equilibrium 
between aqueous solution of high molecular weight PEO and crystalline PEO is 
never realized when the PEO is bound to a surface or exists in a network because 
the effective chain molecular weights are too low and the hydroxyl containing 
unit, by which the PEO sequence of PEO is tied, acts as a diluent comonomer. 
This depresses the crystalline melting point of PEO in the anhydrous state which 
is further depressed by the imbibition of water from plasma. Therefore, the 
surface presented to the blood is "liquid-like,1I capable of segmental motion and 
fluctuation constrained only at the chain ends. 
The passive behavior of PEO towards cellular components can be 
considered an extension of this theory because cell membranes are coated by a 
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hydrated layer of long-chain glycocalyx molecules. George Bell has addressed 
the thermodynamics of cell adhesion in which the steric compression resulting in 
repulsion of the polymer chains plays a major role. (48) He describes the 
repulsive force at distance 8 given by F(8) as a function of the free energy of 
nonspecific repulsion per unit area of contact r(8): 
I" (S) = s: F(s) dS. (6) 
Qualitatively, the repulsive energy falls roughly as the reciprocal of the 
separation distance out to a distance, after which it drops more rapidly. A 
parameter g is developed as a measure of the combined thickness of the polymer 
layers and the ease with which the polymer layers between cells can be 
compressed. Theoretical estimates of g can be derived by considering the 
statistical mechanics of chain molecules anchored to rigid surfaces. 
In summary, the apparent inertness of PEO towards the adsorption of 
proteins and cells is due to the unfavorable entropy of mixing of two long chain 
molecules, an active repulsion force generated by steric exclusion and 
interaction parameters and the imbibition of water molecules by an amorphous 
already hydrophilic material leading to a flexible, liquid like surface. 
1.2.3 Biomedical and Biochemical Applications 
Low molecular weight poly(ethylene oxide)s are widely formulated in 
ointments because of their broad compatibility and water solubility. This 
characteristic permits the ointments to be readily washed off with water. These 
rather inert polymers do not interfere with release of medications and can be 
applied to both moist and dry skin areas with equal ease. PEO with molecular 
weights ranging from 1,000 to 4,000 are used as suppository bases. The softening 
point of the suppository can be controlled by the relative amounts of the higher 
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or lower molecular weight PEO in the formulation. PEO is also used as a dry 
binder, in tablet coating, and for lubrication in the formulating and manufacture 
of compressed tablets. In cosmetics, PEOs are formulated in creams, lotions, 
cakes, sticks, and powders. 
PEO polymers have found a number of clinical applications and are the 
basis of many commercial products. Vigilon TM is a radiation crosslinked high 
molecular weight PEO which swells to a high degree with water and is sold as a 
sheet wound covering material. A contraceptive sponge which has been well 
received in the USA is a crosslinked PEO foam containing the spermicide 
nonoxynolphenol. Smith and Nephew have patented a wound healing laminate 
described by Lang (49) in which a hydrophilic open-celled PEO foam is 
sandwiched between an inner poly(urethane) open-pore net and an outer 
continuous layer which prevents the ingress of bacteria and controls the egress 
of water. 
Poly(ethylene oxide) has found numerous applications in both gas and liquid 
chromatography. Castello et ale have evaluated the retention characteristics of 
PEO used as liquid phases in gas chromatography. (50) Effects of molecular 
weight, temperature and of the effect of the hydroxyl group were examined in 
eight different grades of PEO, and their activity coefficients were calculated. 
The presence of impurities was found to significantly affect these experiments. 
The adsorptivity of glass capillary columns has been suppressed by 
application of a thin nonextractable layer of Carbowax TM, high molecular 
weight PEO which is highly polydisperse, to the glass surface. (51) The 
properties of PEO surfaces were found to differ greatly with the etching 
technique used on the glass, the type of glass and the procedure of Carbowax™ 
application. Columns prepared from etched Pyrex glass showed the highest 
stability, and have been used regularly for the separation of polycyclic aromatic 
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hydrocarbons at temperatures up to 300oC. By using a column packing consisting 
of chemically bonded PED 20M on Sepharose 6B and an isotonic buffered solution 
containing dextran T40 and T500 as mobile phase, Matsumoto et oZ. were able to 
separate human blood cells and studied the influence of mobile phase 
composition on the retention behavior. (52) When neutral salts, such as sodium 
chloride, were added to the mobile phase while maintaining the isotonicity, an 
increase in the retention volumes of erythrocytes, granulocytes, and lymphocytes 
was observed. In a similar exclusion chromatography procedure, PED was used 
at low concentrations to passivate controlled pore glass and prevent the 
adsorption of rabies virus. (53) 
Ling and Matthiasson explored the possibility of using PED with 
intermediate hydrophobicity as ligands in hydrophobic interaction 
chromatography. (54) In this procedure, glucose oxidase was modified by 
covalent attachment of monomethoxypoly(ethylene glycol) and conjugation with 
gentamicin. Two fractions were obtained when the product was run on 
monomethoxypoly(ethylene glycol)-Sephadex at high ionic strengths. 
The behavior of solutions containing globular proteins and PED has been of 
great interest to protein chemists. The only noticeable effect of PED on protein 
structure is the shift of the pK of the ionizable groups at high PED 
concentration. (55) In some situations, the use of PED has definite advantages 
over the use of high salt concentrations, where salting-in and salting-out 
phenomena and specific interaction with both cations and anions complicate the 
interpretation of results and the extrapolation to well defined, biologically 
relevant states. (56) To validate the theory of volumetric displacement put forth 
by Laurent, (57) Hasko et oZ. (58) studied the solubility of plasma proteins at 
various pH values as a function of PED concentration and were able to develop 
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equations which describe the relationship between protein solubility and PEO 
concentration. 
When PEO is used for the fractionation and purification of proteins from 
human plasma as an alternative to cold ethanol precipitation techniques, it can 
be removed from these preparations by adsorption chromatography on 
polystyrene beads. (59) PEO concentrations were reduced by 80 percent in IgG 
preparations by this procedure. It was determined that the oxyethylene groups 
of the PEO are involved in the adsorption to the polystyrene Biobeads TM and 
that this adsorption increases with decreasing mean molecular weight. 
Poly(ethylene oxide) has recently been reported to stabilize solutions of 
dissolved proteins and to prevent their denaturation and aggregation. Thurow 
and Geisen have demonstrated that insulin solutions can be stabilized and 
protected from surface-induced adsorption and aggregation by the preadsorption 
of PEO-PPO-PEO triblock and related copolymers onto hydrophobic 
surfaces. (60) Suzuki et aZ. similarly used PEO to stabilize IgG solutions and 
found that the formation of dimers and trimers of IgG was prohibited by the 
addition of PEO. (61) 
Immunologists have recently used PEO to modify proteins and drugs by the 
covalent attachment of PEO chains to produce a molecule with minimal 
antigenicity. (62) Attachment of PEO in sufficient quantities to a protein often 
produces a conjugate which circulates for extended periods in the blood and does 
not elicit an immune reaction. (63) Abuchowski et aZ. have altered the 
immunological properties of a number of enzymes and drugs by the covalent 
attachment of PEO. (64,65,66) 
The attachment of PEO to oligopeptides has produced soluble conjugates 
which enable IH-NMR conformational studies to be performed. (67) A thorough 
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knowledge of the conformation of proteins and biologically active peptides is 
necessary for the understanding of their structure-activity relationships. 
Poly(ethylene oxide) surfaces are becoming recognized as exhibiting 
properties offering an excellent candidate material for biomaterial applications. 
To date, PEO surfaces which have been used for biomaterials and medical 
devices applications generally consist of PEO block copolymers. Nagaoka et ale 
prepared hydrogels containing methoxy poly(ethylene glycol) monomethacrylates 
with PEO side chains of various lengths and investigated their interactions with 
blood components. (68,69,70) These investigators have shown that the surface 
mobility of PEO chains is maximal when n, the number of repeat units, 
approaches 100. They further showed that a PEO graft copolymer (many free 
ends) is more effective than a network or block system for minimizing the 
adsorption of blood components including proteins and platelets. 
The adsorption of proteins onto a series of oligomers, all containing ethers 
in the molecules copolymerized with ~ -hydroxyethyl methacrylate {HEM A), was 
studied by Lin et ale (71) The water content of these copolymers was tested and 
the adsorption of albumin was studied using radiotracer techniques. It was found 
that there is an enhancement of albumin adsorption by ether groups which is also 
found in the copolymers having higher water contents than that of poly(HEMA). 
However, these investigators did no surface characterization of the copolymer 
systems and their apparently contradictory results may stem from microdomains 
of the hydrophobic portions of the system present on the surface. 
Matsuda et aZ. have done extensive testing of hydrophilic segmented 
polyurethanes containing PEO as the soft segment in which the hard segments 
cluster to form the domain dispersed into the matrix phase of the soft 
segments. (72) The in-vitro blood/material interactions show that both contact 
phase activation of plasma intrinsic coagulation pathway and platelet adhesion 
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are much greater for the hard segment analogous polymer than for soft segment 
versions. The least adsorptional and adhesional behaviors of platelets and plasma 
proteins were observed in the hydrophilic segmented urethane systems. 
Similarly, Merrill and Salzman have observed the platelet compatibility of 
hydrophilic segmented polyurethanes containing PEO soft segments. (73, 74) 
According to their studies, amorphous PEO swollen in water appears to interact 
little, if at all, with proteins including at least some of those relevant to blood. 
When incorporated into networks having defined surfaces, PEO seems to favor 
little adsorption of platelets and this adsorption is independent of the material 
used as a junction of the networks provided this material is not accessible to the 
proteins or platelets of blood. 
1.3 Heparin Background 
1.3.1 Structure and Pharm acology 
Herapin is a sulfated polysaccharide well known for its anticoagulant and 
antithrombotic properties. It was discovered by McLean in 1916 (75) but was not 
introduced into routine clinical use until the 1930's. Heparin is present in 
numerous animal and human tissues but is found in the highest concentration in 
the lung and intestinal mucosa, which are used for commercial sources of both 
animal and human heparins. It is synthesized in the mast cells. The enzymatic 
steps involved in the biosynthesis of heparin were elucidated by Riesenfeld. (76) 
Commercial heparin preparations exist as a population of sulfoglucosamine 
and hexuronic acid units linked by 1-4 glycosidic bonds to form linear anionic 
carbohydrate molecules ranging in molecular weight from 3,000 to 40,000 
daltons. The main sugars occurring in heparin are: 1) Z-deoxy-Z-
sulfoamino-~-D-glucose; Z) ""-L-iduronic acid Z-sulfate (Z-sulfo-iduronic acid); 
3) Z-acetamido-2-deoxy-tA -D-glucose (acetylglucosamine); 4) ~ -D-glucuronic 
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acid; and 5) ci(. -L-iduronic acid, in order of their decreasing concentrations. (77) 
Structures of these sugar units are shown in Fig. 4. The variations in molecular 
weight coupled with single sugar unit variations lead to the very polydisperse 
nature of commercial preparations. 
It was found that approximately one third of commercial heparin 
preparations are active in their ability to bind to antithrombin m (AT-III). (78) 
Even this small fraction is highly polydisperse, ranging in molecular weight from 
7,000 to 20,000. A unique tetrasaccharide sequence was found to be present in 
the active heparin fraction. (79,80) The tetrasaccharide sequence (L-iduronic 
acid, N-acetylate-D-glucosamine 6-sulfate, D-glucuronic acid, N-sulfated-D-
glucosamine 6-sulfate) was found in only 2.6 percent of the molecules present in 
the inactive fraction, while every molecule in the active population possessed at 
least one tetrasaccharide sequence. (79) Studies conducted to define the 
location of the unique tetrasaccharide sequence in heparin have demonstrated 
that these are located at or near the non-reducing terminus of the heparin 
chain. (81) Dusulfination of bulk heparin leads to a rapid loss in anticoagulant 
activity and yet the L-iduronic acid is not sulfated in the tetrasaccharide 
sequence. (82) There is a strong correlation between the anticoagulant activity 
and the relative abundance of the unique tetrasaccharide sequence, suggesting 
that this represents the AT-m binding site. However, because additional 
properties such as molecular weight, thrombin affinity and charge density can 
markedly affect the activity of heparin, the molecule must have multiple 
functional domains. (83, 84) 
Other chemical groups are present in the molecular structure of heparin. 
Amino acids, in particular glycine, cysteic acid, alanine, aspartic acid and serine, 
have been found (between 0.3 and 2.3 weight percent depending upon the 
source). (79) These amino acids can be covalently linked to heparin or may 
CH2JSO 3 C~OH 
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(1 ) (2) (3) (4) (5) 
FiQure 4. The main sugars found in the heparin molecule which are linked by 1-4 glycosidic bonds. 1) Z-
deoxy-Zsulfoamino - J..-D-glucose; Z) a-L-iduronic acid Z-sulfate (Z-sulfoiduronic acid); 3) Z-acetoamido-
Z-deoxy-~-D-glucose (acetylglucosamine); 4) (?> -D-glucuronic acid; and 5) rA -L-iduronic acid. tv U1 
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simply be ionically bound and represent impurities from the native heparin 
protein complex. 
The anticoagulant effect of heparin is due to its interaction with the 
proteolytic enzyme, thrombin. The generation of thrombin represents the 
central event in the coagulation of blood. Its formation proceeds via two 
pathways, the intrinsic and extrinsic, in which plasma proteins initiate a cascade 
of sequential reactions. These pathways have been summarized previously and 
will not be recounted here. (85,86) However, heparin has a variety of 
interactions with coagulation factors and cofactors including Factor Xa, XIIa, 
IXa, antithrombins and thrombin. Heparin has been shown to independently 
induce platelet aggregation and to potentiate platelet release reactions caused 
by exogenous agents. High molecular weight fractions are apparently more 
reactive toward platelets and platelet function than low molecular weight 
fractions. (87) Numerous other pharmacological functions have been reported for 
heparin which affect the activity of more than 50 enzymes. (88) For example, 
heparin can trigger the release of lipoprotein lipases from endothelium, adipose 
tissues and liver, (89) initiate secretion of histaminase from intestinal mast 
cellsJ (90) and inhibit secretion of aldosterone resulting in lower adrenal 
function. (91) 
By far the most significant and extensive interaction of heparin is its 
ability to bind AT-m and thrombin, increasing the inactivation rate of thrombin 
up to 500-fold. The presence of a reactive serine center on thrombin is crucial 
to its binding to heparin as demonstrated by studies which artifically block this 
amino acid .• (92) While the exact mechanism of the heparin/AT-m/thrombin 
reaction is currently unknown, three predominate theories have emerged. 
The most popular of these is that heparin binds to the positively charged 
lysine residues on the AT-m molecule thus forming a heparin/AT-m complex. 
27 
This induces a conformational change in the A T-m molecule, rendering the 
active arginine center more accessible to the thrombin, thus neutralizing it from 
further interaction with fibrinogen (93,94) (Fig. 5). This would infer that active 
serine sites on other coagulation proteases would also bind AT-ill and that this 
reaction would be enhanced by the presence of heparin. This was found to be the 
case for Factor XIIa, (95) Factor IXa, (96) and Factor Xla. (97) However, the 
reaction with Factor Xa apparently occurs by a different mechanism. (98) This 
lends more evidence for multiple functional domains on the heparin molecule. 
In a second theory of the mechanism of heparin's action, the high binding 
constant of thrombin with heparin supports the idea that heparin first binds to 
thrombin, and then as a complex binds to AT-m. However, this mechanism is 
thought to be of minor importance in the physiological state. (99) The third 
model, based on the binding constants of AT-m and thrombin, suggests that both 
these molecules bind to different sites on the heparin molecule and, due to their 
proximity, an enhancement of the rate of reaction is observed. (100) 
Regardless of the exact mechanism, it is evident that heparin works in a 
catalytic fashion. (101) The initial reaction velocity can be described by the 
general rate equation for a random-order two reactant, enzyme catalyzed 
reaction which is mathematically identical to the "template" model. (102) In 
principle, the template model for the heparin mechanism implies that the binding 
of thrombin and AT-m to heparin is required for the catalytic activity of 
heparin. (103,104) This also supports the position that heparin can be released 
for further A T-m binding after the thrombin-AT-m complex has been 
formed. (105) It has been found that the binding of thrombin to the heparin/ AT-
m complex results in the discharge of heparin, leaving the thrombin/AT-III 
complexes with little ability to bind heparin. The binding affinity of the heparin 
Arginine Sites 
Active Serine \ 
Center ~ 
.. 
Figure 5. Schematic representation of the mechanism of heparin, antithrombin 
m (AT-III) and thrombin interaction. Heparin binds to the positively charged 
lysine residues on the AT-m molecule resulting in a subsequent conformational 
change in the A T-m molecule. This renders the active arginine center more 
accessible to the thrombin serine residue facilitating binding. 
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molecule for A T-m remains unchanged following the release of the 
thrombin/ AT-m complex. 
1.3.2 Immobilized Heparin Materials 
Due to the numerous pharmacological effects associated with heparin and 
the high risks involved in long term systemic heparin dosing, efforts have been 
made to decrease the risk of anticoagulation therapy for patients using 
biomedical devices in contact with blood. Many investigators have attempted to 
incorporate heparin and other anticoagulants into or onto the polymeric devices 
themselves. These have taken a variety of forms, but may be considered in two 
categories: 1) materials providing a controlled release of heparin at the 
interface, either by exchange with blood components or by diffusion through the 
polymer, and 2) materials which have the pharmacon immobilized on the surface. 
In light of the recent, comprehensive review of the approaches taken by 
numerous investigators to modify polymers with heparin, (106) a summary of the 
immobilized herapin surfaces is given in Table I. Some of these approaches have 
demonstrated promising results. 
Part of the difficulty encountered in the testing of these surfaces is due to 
the complex interactions and protein adsorption reactions which occur. For 
example, the increased clotting times observed may be a result of heparin 
leaching from the surface. They may also be attributable to the protein 
interactions with the highly negative surface. The surface may actually be 
coated with a layer of adsorbed proteins which act to passivate the material and 
with time the blood proteins and platelets may never really be in contact with 
the heparin surface. Many studies have not determined whether the 
immobilization of heparin through a specific functional group affects the 
anticoagulant activity of the heparin. It may be that blocking these groups by a 
Table I 




Grode (108) Covalent coupling of a heparin I 
cyanuric chloride adduct to amino-
propyl-triethoxysilane treated 
silicone rubber. 
Radiation grafting of polystyrene, 
chloromethylated, then treated 
with heparin Icyanuric chloride 
adduct. 
Merrill (109) Glutaraldehyde crosslinking of 
heparin to poly(vinyl alcohol). 
Lagergren (110) Cationic surfactant adsorption 
ontopolypropylene followed by 
ionic binding of heparin and 
subsequent crosslinking with 
glutaraldehyde. 
Schmer (111) Direct coupling of heparin to 
cyanogen bromide activated 
agarose. 
Comments 
Produces a permanent heparin surface; effects of form-
ing the heparin I cyanuric complex on the anticoagulant 
activity were not investigated. Prevented thrombus 
formation for 6 months. 
Also permanent surface and increased 
whole blood clotting times 
I 
Permanent crosslinked heparin surface that 
adsorbs coagulation factors; Decreased platelet 
function; No investigation of heparin crosslinking 
effects; No release of heparin from surface detected. 
No clotting observed after 3 hours of blood contact; 
Shunts were viable for 12 hours; Leaching of -3% of 
heparin from surface during initial 10 hours; Clotting 
times were a function of degree of crosslinking; 
Improved platelet compatibility. 
Less heparin immobilized onto the spacer arm than 
with other methods used. 
w 
o 
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Coupling of heparin to putrescine 
on putrescine derivatized agarose. 
Coupling was via primary amine groups on heparin 
Greater amounts of heparin than on the direct coupling 
method; Increased ability to bind antithrombin III. 
Coupling of heparin to amino caproyl Indistinguishable from above method. 
to amino caproyl derivatized 
agarose via carbodiimide. 
Heparin- methyl methacrylate 
copolymer 
Heparin coupled to agarose via 
an amino-ethyl spacer arm. 
Heparin coupled to poly(vinyl 
alcohol) via acetal bridge of 
various aldyhydes,then applied 
to hydroxylated styrene-butadiene 
-styrene block copolymer. 
Dose related anticoagulant activity observed due to 
copoymer consisting of heparin core with p-MMA 
chains extending out. Increased clotting times result of 
ionically bound heparin leaching from surface. 
No leaching of heparin upon storage; Saturation of 
heparin binding sites and significant binding of Factors 
IX, XI, and antithrombin III. 
Insignificant leaching of heparin; Increased partial 
thromboplastin and recalcification times observed; 
High shear rates however, produced no differences 
between heparin surfaces and controls; Evidence for 
binding of thrombin to heparin contrary to popular 
belief of heparin mechanism. 
w 
..... 








Coupling of heparin to cyanogen 
bromide activated sepharose. 
Coupling of heparin to Qyanogen 
bromidtl activated poly(hydro.xy~ 
ethyl methacrylate), 
Coupling of heparin to QyanQgen 
bromide activated PQly(vtnyl 
alcohC)I), 
Partially degraded fragment$ of 
heparin coupled to polyethylene-
amine activated poly(ethylene). 
Heparin coupled via various length 
alkyl spacer groups to diaminoal-
kane derivatized sepharose, and 
cellulose, agarose. 
Heparin coupled via various 
length alkyl spacer gro~ps to 
polyurethane. 
Lindberg (120) Crosslinked heparin with glutar-
aldehyde stabilized by 
hexadecylamine. 
Comments 
Greatly prolonged plasma recalcification times; 
Indication that using amine groups of heparin 
renders it incapable of interacting with antithrombin III. 
Greatly prolonged recalcification times; 
IndicAtion that Y§ing Amine QrQUps of heparin 
tenders it tnaapable of interacting with antithrombin III~ 
No indication of prQlongation of recalcification times. 
Indioatio.n th§t u$ing .mine grQups of heparin 
re.nder§ it Incapijble of Interacting witl1 Antithrombin lilt 
Surface is stable; Heparin frlgments capable of 
reacting with thrombin; Increaled whole blooQ 
clotting times observed. 
Increasing activated partial thromboplastin times 
with increasing spacer arm length; no adverse Inter-
action with platelets. 
Heparin retained its activity towards thrombin and Factor 
Xa but caused only slight increase of partial thrombo-
plastin times; No significant release of heparin from 
surface; Decreased thrombus formation in implanted 
shunts. 





reaction similar to those used for the immobilization process also results in loss 
of anticoagulant activity. Several of the heparinized polymers involve 




2.1 Derivatization of Poly(ethylene oxide) 
Four different derivatives of PEO of two molecular weights were 
synthesized using modifications of the procedure developed by D. Gregonis 
(personal communication) (Fig. 6): PEO-bis isocyanate, PEO-bis isothiocyanate, 
PEO-bis chloroformate, and PEO-bis thiochloroformate. Each of these 
derivatives was synthesized starting with PEO molecular weights of 6,000 and 
18,000 (Polysciences). The PEO s were dried under vacuum overnight prior to 
use. 
2.1.1 Isocyanates 
The PEO was dissolved in tetrahydrofuran (THF) under nitrogen. A 20 
percent excess of 2.2 M n-butyl lithium (Aldrich Chemical) in hexane was added 
and stirred for 1 hour. A 20 percent excess of tosyl chloride (Aldrich Chemical) 
was added to the solution and the reaction mixture stirred for 3 days (Step I in 
Fig. 7). 
The lithium salt of cysteamine was prepared (Step n in Fig. 7) by adding 
equivalent amounts of n-butyl lithium to cysteamine (Aldrich Chemical) in THF 
dropwise to the solution and stirring overnight. The PEO-tosylate solution was 
added to the cysteamine salt and the mixture stirred for 3 days (Step m in Fig. 
7). THF was removed under reduced pressure and toluene was added to dissolve 
the residue. The toluene was then washed with 40 percent KOH four times. The 
toluene was removed under reduced pressure and the amine capped PEO was 
Four Derivatives of Poly( ethylene 
1. PEO - BIS ISOCY ANA TE 
O=C=N - PEO - N=C=O 
2. PEO - BIS ISOnnOCY ANATE 
S=C=N - PEO - N=C=S 








CI-C-O- PEO -O-C-Cl 
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Figure 6. The four derivatives of poly(ethylene oxide} synthesized for 
immobilization onto quartz substrates. The bifunctional molecules permit 
attachment to the substrate with the extension of the other free reactive end 




HSCH2CH2NH2 + n~butyllithium -------->U+ -SCH2CH2NH2 + CH3CH2CH2CH3 l' 
III. 
IV. 
PEOeli-amine + cocr2 --> O=C=N-CH2CH2-S -(OCH2CH2)n-S CH2CH2N=C=O + HCr 
PEO-bis Gocyanate 
H2NCH2CH2S -(OCH2CH2)n-SCH2CH2NH2 + CSCI2 ------> 
S=C=N~CH2CH2-S -(OCH2CH2)n-S CH2CH2N=C=S + HCr 
PEO-bis isothiocyanate 
v. 
H-(OCH2CH2)n-OH + Cse'2 -> CI--¥-(OCH2~)n-Of,-CI 
S S 
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Figure 7. The chemistry involved in the synthesis of the four derivatives of 
poly{ethylene oxide). 
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reprecipitated three times in diethyl ether (cold) from a minimum amount of 
methylene chloride. 
To determine the degree of conversion of PEO to diamino-PEO, the amine 
capped PEOs were titrated using 0.01 M perchloric acid (Fisher Scientific) and 
acetic acid anhydride {Fisher Scientifid. Potassium acid phthalate 
(Mallinckrodt) was used as a standard in the titration. The conversion was 
determined to be 85 percent. 
The amine capped PEO's were then reacted with a 100 percent excess of 
phosgene in toluene (12. percent) (MCB) and stirred for 2. hours (Step IV in Fig. 
7). The excess phosgene was removed by distillation and the toluene removed by 
rotoevaporation. In the case of the thiocyanate, a 100 percent excess of 
thiophosgene in toluene (Aldrich Chemical) was used instead of phosgene. 
Infrared spectra of each of the derivatives were run (Figs. 8a and 8b). All 
derivatives were stored under nitrogen until used to prevent hydrolysis of the end 
groups. 
2..1.2. Chloroform ates 
The chloroformate derivatives were prepared by dissolving PEO (hydroxyl 
terminated) in toluene (Step V in Fig. 7) to which was added a four times excess 
of phosgene or thiophosgene. The reaction was accomplished by stirring 
overnight and heating to reflux, then removing the solvent until the solution was 
no longer acidic. The toluene was removed by rotoevaporation. Infrared spectra 
were run to determine any remaining hydroxyl from the OH stretching region at 














CJ 20 ~ A 
~ O~ ______ ~~ ________ ~~ ____ ~~ ____ ~~~ ____ ~~ 
4000 3000 2000 1600 1200 800 
Wavenumber cm-1 
38 
Figure 8. Infrared spectrum of poly(ethylene oxide} derivatives. a. bis-
isocyanate MW 6,000; b. bis-isothiocyanate MW 6,000; c. bis-chloroformate MW 
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2.2 Quartz Substrate Preparation 
2.2.1 Cleaning 
The quartz slides (7 x 10 mm, ESCO Products) were prepared for PEO 
immobilization by soaking in a dichromate-sulfuric acid solution (25 ml Monostat 
Chromerge chromic acid in 4.1 kg of concentrated sulfuric acid) at 800 for 20 
minutes. The slides were then rinsed with distilled water four times for 3 
minutes each, rinsed four times in ethanol and radio frequency glow discharged 
at 35 watts (Plasmod, Tegal) under 200u pressure oxygen for 3 minutes. The 
slides were then heated to 1000C overnight to remove any residual water. 
Wilhelmy plate contact angle and X-ray photoelectron spectroscopy spectra 
(XPS) were obtained to determine any residual contamination. If the carbon 
content of the XPS spectra of clean surfaces exceeded 12 percent, or if the 
contact angle was greater than 00 and/or demonstrated hysteresis, the slides 
were not used. 
The quartz beads were 50u Unispheres™ (Ferro Corp). These were placed 
in the same dichromate-sulfuric acid solution and stirred for 20 minutes. They 
were then rinsed extensively with distilled water by filtering through a buchner 
funnel until no remaining acid color could be detected visually. They were then 
rinsed with. an additional 16 liters of distilled water through the funnel. The 
beads were dried overnight at 1000C. To determine cleanliness, XPS spectra 
were run by pressing the beads into indium foil and scanning for carbon and 
sulfur remaining from the sulfuric acid. 
2.2.2 Vapor Phase Silanization 
All glassware used for the silanization was oven dried (1000C) following the 
cleaning procedure. The clean quartz slides were vapor phase silanized 
immediately after removing from the 1000 oven by placing them in a vapor 
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chamber through which 10 ml r -aminopropyl-triethoxysilane (APS) (Aldrich 
Chemical) in 250 ml dry p-xylene (Fisher Scientific) was refulxed for 12 hours. 
The APS had been recently distilled to rem ove any dimer or trimers and stored 
under nitrogen at 4oC. They were then refluxed for an additional 12 hours in 
toluene dried over molecular sieve, rinsed to remove any unbound APS. XPS 
analysis was done to determine the extent of silane coverage (see Section 3.1). 
2.2.3 Silanization of Quartz Beads 
The silanization of the quartz beads was done in a round bottom flask 
fitted with a nitrogen bubbler, a condenser and thermometer. The beads were 
suspended in dried p-xylene by use of a stir bar and the nitrogen bubbler. After 
perfusion with nitrogen for 2 hours, the nitrogen was turned off. Ten ml distilled 
APS were then added to the flask and the mixture was refluxed for 12 hours. 
After removing the APS/xylene mixture and rinsing the beads with toluene three 
times, the beads were then refluxed with toluene for an additional 12 hours. XPS 
analysis was done to determine the extent of silane coverage. 
2.3 Poly(ethylene oxide) Immobilization 
2.3.1 Poly(ethylene oxide} Coupling to Quartz Plates 
The conditions for the immobilization of the PED derivatives were 
established from experiments to determine the optimum time and concentration. 
Initially, PED derivatives of various molecular weights and concentrations were 
dissolved in methylene chloride, and then added to the silanized slides in staining 
jars. In order to minimize the formation of loops by the PED coupling via both 
ends, the highest concentration of PED solution was used. The results indicated 
that raising the PED solution concentration greater than 3 percent did not 
increase the PED coupling to the surface. These early coupling experiments 
demonstrated that some of the reactive end groups, particularly the 
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chloroformates, had been hydrolyzed before coupling to the silane coated slides. 
It was determined that the hydrolysis was due to the condensation of moisture 
from the air during the evaporation of the methylene chloride. 
Therefore, the PEO derivatives were dissolved in chloroform, which is less 
volatile and the coupling efficiency was again determined. In the presence of 
atmospheric moisture, however, the end groups were still being hydrolyzed prior 
to coupling. 
In order to prevent this problem, the coupling reactions were performed in 
a nitrogen glove bag. All glassware and solvents were purged for 2 hours with 
nitrogen prior to beginning the reaction. The final reaction conditions were a 1.5 
percent (w Iv) solution for the 6,000 molecular weight derivatives and 3 percent 
(w Iv) for the 18,000 derivatives. This was done to normalize the molar ratio of 
end groups available for the reaction in both molecular weights. From the 
results of the coupling efficiencies as a function of time, it was determined that 
a minimum of 12 hours coupling time be used (Fig. 9). The reaction was left 
overnight, after which the slides were rinsed with methylene chloride three 
times to remove the unbound PEO. The reaction involved in the coupling of the 
four derivatives is given in Fig. 10. Because of early experiments indicating 
instability of PEO, a large brown cardboard box was placed over the entire 
nitrogen glove bag assembly in an attempt to exclude room light which has been 
indicated as a potential cause of chain scission. (121) The reactive end groups on 
the PEO chains not involved in the coupling reaction were hydrolyzed with water 
before analysis. However, no water was used if the slides were to be used for 
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Figure 9. The elemental percent of carbon of the PEO immobilized surfaces 









Figure 10. The reaction involved in the coupling of the four clerivatives of PEO 
to the silanized quartz substrate. The amine of the silane couples to the 
functionalized PEO.. Using a large excess of PEO minimizes the possibility of 
the formation of loops resulting from both ends of the PEO coupling to the 
surface. 
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2..3.2. Poly(ethylene oxide} Coupling to Quartz Beads 
Coupling of the PEO derivatives to the quartz beads was achieved using an 
apparatus similar to the APS siIanization described above. The silane treated 
beads were suspended in methylene chloride by using a magnetic stir bar and 
nitrogen bubbler. The PEO derivatives were added to this mixture so as to make 
1.5 percent and 3.0 percent solutions of the 6,000 and 18,000 derivatives, 
respectively. The flasks were covered with aluminum foil to exclude room light 
and left overnight. They were then rinsed three times with methylene chloride 
to remove the unbound PEOs. Those beads not used for further reaction with 
heparin were then removed from the flask and rinsed with ethanol and distilled 
water. 
2..4 Heparin Immobilization 
2..4.1 Coupling to Quartz Plates 
The PEOreacted slides were taken directly from the PEO immobilization 
reaction vessels and rinsed once with methylene chloride. This procedure was 
conducted in the nitrogen glove bag in order to prevent end group hydrolysis. 
The quartz slides were then immersed in a saturated solution of bovine intestinal 
mucosa sodium heparin (Diosynth) in formamide (MCB) with 1 percent pyridine 
added as a catalyst. The heparin was used as received. The heparin solution was 
prepared one day prior to use and stored under nitrogen to eliminate any possible 
moisture contamination. The reaction was left for 3 hours. The slides were 
withdrawn from solution and rinsed in ethanol, water, ethanol and methylene 
chloride for drying. They were stored under vacuum for further drying until 
analysis. 
The coupling of the heparin is presumed to occur through the hydroxyl and 
the relatively few amine groups of the heparin molecule and should be 
48 
instantaneous. Of course, any carboxyl groups on the heparin would be expected 
to react with the PEO derivatives, and this would presumably be accomplished 
faster than reaction with the hydroxyl groups due to their higher reactivity. 
However, the resultant anhydride type linkage would be unstable and 
rearrangement to the urethane or urea coupling would be expected to occur. For 
this reason, the reaction was allowed to run for 3 hours. 
2.4.2 Coupling to Quartz Beads 
The immobilization of heparin to the quartz beads was achieved by 
transferring the PEO coupled beads to another round bottom flask in the nitrogen 
glove bag. The saturated formamide/heparin solution with 1 percent pyridine, 
which had been stored under nitrogen overnight, was then added to the flask and 
immediately fitted with the nitrogen bubbler and stir bar. This flask was left for 
3 hours, after which the beads were rinsed three times with ethanol, twice with 
distilled water, and once with methylene chloride for drying. The beads were 
then stored under vacuum for further analysis. 
2.5 Quantitation of Immobilized Heparin 
2.5.1 Tritium Labeling of Heparin 
The procedure used for the tritium labeling of heparin was a modification 
of that used by Dottavia-Martin et ale (122) This procedure uses sodium 
cyanoborohydride as the reducing agent because it is stable in aqueous solutions 
and may be used at pH 7.0. Briefly, the procedure entailed mixing 300 uCi 3H-
formaldehyde (New England Nuclear) diluted with 2.0 ml double distilled water 
and 1 gm heparin (Diosynth) dissolved in 2.0 ml double distilled water. This 
mixture was diluted with an additional 10 ml water and then 0.7 gm sodium 
cyanoborohydride was added and left stirring for 24 hours. The heparin was then 
precipitated out of solution using 200 ml ethanol and freeze dried. The labeling 
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procedure used results in a labeled methyl group coupled to the free amines. The 
specific activity of heparin was determined by preparing five solutions of known 
amounts of heparin, adding scintillation cocktail to make 10 ml and counting on a 
Beckman LS 7500 scintillation counter. The background of 47.3 dpm was 
subtracted from all samples. The specific activity of the labeled heparin was 
determined to be 63,530 .:!:. 1,042 dpm/mg. The 3H-heparin was stored at 40C 
until used. 
2.5.2 Quantitation Procedure 
Quantitation of the immobilized heparin was performed by reacting PEO-
bis isocyanate derivatized (MW 6,000 and MW 18,000) beads with a saturated 
solution of 3H-heparin in a formamide/pyridine solution similar to that described 
in Section 2.4.2 for 3 hours. Various quantities of these labeled beads were 
weighed out, total surface area calculated and mixed for 4 hours with minimum 
amounts of concentrated NaOH in order to hydrolyze the heparin from the 
surface. Aliquots of the NaOH were withdrawn and counted after addition of 
enough scintillation cocktail to make 10 mls. Triplicate samples of each bead 
solution were used. Controls consisted of clean quartz beads and PEO-bis 
isocyanate without heparin. For each molecular weight of the PEO used, the 
quantity of heparin was determined per unit surface area. 
2.5.3 Heparin Depletion From Surface 
In order to determine if heparin was leaching from the surfaces used for 
the activity tests, two different sets of heparin reacted beads were tested. The 
first group was the beads which were rinsed in the same manner as those used in 
the initial whole blood clotting tests which failed to produce clots even after 2 
hours. These beads were washed repeatedly with PBS, each rinse being 
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subsequently counted. Typically, after the eighth washing with 10 ml PBS no 
more heparin was detected. 
The method used for the second group of beads was ultimately determined 
to be the method of choice in the whole blood clotting tests. This procedure 
involved soaking the beads in PBS for at least 2. hours, then rinsing three times 
with distilled water and drying. These beads were then rinsed repeatedly in the 
same manner as those above. All rinses were counted. Even after the first 
rinse, no heparin was detected in solution, indicating no leaching from the 
surface. 
2..6 Radiolabeling of Bovine Serum 
Albumin and Antithrombin m 
The method used for the iodination of protein for quantitative analysis of 
protein adsorption was a modification of the Chloramine T method, originally 
developed by Greenwood et ala (12.3) and modified by Chuang. (12.4) Briefly, this 
involves the iodination of the tyrosine residues present in the protein molecules 
using 12.5I-sodium iodide. A commercial Chloramine T kit was purchased from 
Amersham Corp. and 500 uCi of 12.5I-sodium iodide per 100 ug of protein were 
used. The proteins used were bovine serum albumin Fraction V (Sigma Chemical) 
and Antithrombin m. The AT-m was the generous gift provided by Dr. 
Wickerhauser of the American Red Cross. Both proteins were used as received 
and rehydrated in PBS. Fifty ul of a chloramine T solution (40 mg/10 ml water) 
were added to the protein solution and mixed gently for one minute. Fifty ul of 
a sodium metabisulfite (SMB) solution (48 gm/10 ml water) were added to stop 
the reaction. Removal of the free 12.5_1 from the labeled protein was done 
according to procedures described in (12.4) using plastic mini-columns which had 
the reservoir cut off, allowing solution to flow out the bottom. The tube was 
packed with approximately 1.3 ml of a thick slurry of Sephadex G-2.5 (Sigma) 
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which had been equilibrated for 2.4 hours, and centrifuged piggy-back in a 12. x 75 
cm plastic tube at 400 rpm for 1 minute. 
The effluent was tested for the presence of free 12.5-1 after separation 
with the following procedure: 45 ul PBS, 5 ul 12.5-1 protein, and 50 ul TCA 
solution were added to column 1; column 2. contained 95 ul PBS and 5 ul 12.5-1 
protein. These were centrifuged for 10 minutes at 10,000 rpm. Five ul of both 
control sample and supernatant of the precipitated sample were removed and 
counted. The ratio typically showed that after separation, greater than 95 
percent of the 12.5-1 was bound to the protein. The approximately 5 percent free 
12.5-1 was presumed to not irreversibly adsorb to the surfaces and was accounted 
for in the quantitation by reducing the total adsorbed count by 5 percent. This 
may be an invalid assumption, particularly for the PEO surfaces which may be 
capable of complexing free iodide. This will be discussed later in the results of 
the protein adsorption experiments. 
Efficiency of labelling and specific activities were determined. The 
specific activity of the BSA was found to be about 1.17 uCi/ug and that of the 
AT-m, 0.92. uCi/ug. The labeled protein was stored at 4 0 C until used. Each 
sample was counted twice in a 12.5 1-gamma well counter (Beckman) using 1 
minute counting times. Small aliquots of labeled protein were added to 
unlabeled protein of known concentrations immediately prior to the adsorption 
experiments. 
2..7 Characterization 
2..7.1 X-Ray Photoelectron Spectroscopy 
Photoelectron spectroscopy is very surface sensitive, analyzing the first 50 
-100 A of a polymer surface. It was chosen as the primary means of 
characterization of the PEO and PEO/heparin surfaces because of its 
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quantitative abilities, the ease of differentiation of functional groups, and 
elemental analysis. To analyze the polymer surfaces, the samples are placed 
under high vacuum (10-9 torr), and bombarded with photons from a 
monochromatic X-ray source. The instrument used in this study was a Hewlett 
Packard 5950B spectrometer equipped with a monochromatic Al k -c.. 1,2 source 
at 1487 ev, with anode power of 800 watts. An electron flood gun operating at 
0.6 mA supplied a source of low energy electrons to compensate for charging of 
the sample. Samples of the quartz plates and beads from every reaction were 
analyzed. Carbon IS, oxygen IS, nitrogen IS, silicon 2S and sulfur 2P spectra 
were taken and normalized by their Scofield cross sections. (128) Data were 
stored on a Hewlett Packard 9845 computer which allowed for data analysis. 
Percent elemental composition of the surfaces was determined. A curve fitting 
routine using a least squares fit was applied to the carbon IS spectra of the PEO 
surfaces in order to differentiate the aliphatic, ether, and carboxylic carbon 
species on the surface. It was assumed that all ether carbon detected from the 
surface was due to the PEO. 
XPS spectra were also obtained on heparin powder and underivatized PEO 
as received from Polysciences, Inc. 
2.7.2 Variable Angle XPS 
Variable angle XPS was run on the APS and PEO coupled slides to 
determine thickness and homogeneity of the surface. Photoelectron take off 
angles were varied from 10 - 85°. Using models for both a uniform over layer and 
patchy overlayers of varying thicknesses, these data were fit to the appropriate 
equations. (125) 
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2.7.3 Wilhelmy Plate Contact Angle 
Contact angle measurement by the Wilhelmy Plate method (126) provides 
both advancing and receding angles on either dry or hydrated samples. The 
apparatus used consisted of a Cahn electrobalance supported above a beaker of 
2X distilled water. A thin thread was connected to the electrobalance which was 
used to support the test material as it is submerged and withdrawn from the 
beaker of water. The beaker was raised and lowered at 40 mm/minute. The 
sample chamber was maintained at 30 percent relative humidity and 21 0 C. The 
angles were determined from the following equation: 
measured force Fm = mg +e~ + Pg cos 9- VPg 
or 
e =Fm-mg+Ve s cos f( 
where 
F m is the mass of slide as measured with electrobalance; 
g is the local gravitational force (979.3 dynes/g in Salt Lake City); 
P is the perimeter of the slide; 
~ is the surface tension of wetting liquid (water = 72.6 dynes/cm at 200 C); 
V is the volume of immersed sample at a particular depth, and 
e is the density of wetting liquid (water = 0.998 g/cc at 200 C). 
All treated slides were characerized using this method before and after 
various periods of hydration in PBS. Slides soaked in PBS were rinsed with 
distilled water and air dried prior to determining contact angle. However, it was 
found that the PEO reacted slides were not giving reproducible results presumbly 
because of some noncovalently bound polymer coming off. This will be discussed 
in Section 3.2. 
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2.8 Protein Adsorption Studies 
The adsorption of proteins from solution was determined by two methods. 
Initially, experiments using Total Internal Reflection Fluorescence Spectroscopy 
(TIRF) were done in hopes that conformational information of the proteins 
interacting with the immobilized heparin could be obtained. However, problems 
inherent to the TIRF technique, which at that time had not yet been solved, 
precluded extensive experimentation with this technique. The experiments 
which were done using TIRF were not quantifiable * and for this reason, protein 
adsorption properties of the PED and PED /heparin surfaces were measured using 
125I-Iabeled proteins. 
2.8.1 Total Internal Reflection Fluorescence Spectroscopy 
Total internal reflection is a technique which takes advantage of the 
standing evanescent wave resulting from the superposition of incident and 
reflected radiation at a solid/liquid interface. Complete reviews of this 
phenomenon have been published and will not be discussed herein. (127) Let it 
suffice that internal reflection is dependent upon the refractive indices of the 
two media, the incident angle of radiation, and the amplitude of the electric 
field. The evanescent wave propagates perpendicular to the interface and 
decays exponentially into the less dense medium. In this way, information about 
the molecules at or near the interface can be obtained. Hirschfeld was the first 
to introduce the use of this technique using solid/liquid interfaces in the 
fluorescent mode which requires the presence of fluorescent species at the 
interface. (1 Z9) 
.The TIRF method can now be used for quantitative studies; the quantitation 
method was developed too late to be used in this thesis. (128) 
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In the experiments done here, the intrinsic fluorescence of the tryptophan 
and tyrosine residues of antithrombin m (of which there are six) and other blood 
proteins were excited at 280 nm and the emission collected at right angles to the 
interface at 330 nm. A schematic diagram of the apparatus used is given in Fig. 
11. The excitation beam of the broad band 150 watt xenon high pressure lamp 
(n..C Technology) was focused onto the entrance slit of an excitation 
monochromator (H10-UV, Instruments SA). The narrow band light was 
collimated with a 10 cm focal length UV lens (Oriel) and directed through a beam 
area limiting aperature (Model 1D 1.5, Newport Research Corp.). The beam 
struck at right angles to one face of a fused quartz dove-tailed prism (Harrick 
Scientific) such that it struck the optical interface at a 700 angle. This is 
greater than the critical angle required for total internal reflection. Coupling 
between the prism and quartz slides prepared as described above was facilitated 
by use of glycerol. The reflected beam was discarded. 
The fluorescence emission was collected through the quartz prism and 
directly entered the emission monochomator (HR 640, instruments SA) and 
detected by a photomultiplier tube (Hamamatsu, Ortec model 9210 holder). A 
preamplifier/discriminator unit (model 9302, Ortec) was used to amplify the 
signal and to reject low noise signals. A photon counter (model 9315, Ortec) 
displayed the signal digitally, then converted it to a continuous analog signal 
(D/A model 9325, Ortec) and displayed the data on a strip chart recorder (model 
48, Pharmacia). 
The flow cell design is shown schematically in Fig. 12. It is a modification 
of an earlier design described by Van Wagenen et 01. (130) The modifications 
involved changing the entrance and exit ports to point sources and an elliptical 
rather than rectangular flow volume was demonstrated to exhibit improved 










Figure 11. Schematic of the TIRF apparatus. The components are (UV) UV 
excitation light source; (ExM) excitation monochromator; (S) shutter; (L) 
collamating lense; (P) polarizer; (F) flow cell; (EmM) emission monochromator; 






Figure 12. Components of the TIRF flow cell. The derivatized quartz slide was 
optically coupled to the quartz prism with glycerol. Flow volume created by the 
silastic gasket was 0.8 mI. 
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sample volume was 0.05 cm Silastic TM which sealed the prepared quartz plate to 
the anodized aluminum flow cell. Threaded tubing connectors inserted to the 
base at the ports provided a means for connection of 1.57 mm ID polyethylene 
tubing (Intramedic, Clay Adams). The exit port lead to a waste container. The 
inlet port tubing was connected to a three-way stopcock which was connected to 
syringe held in a syringe pump (341, Sage Instruments). The priming volume of 
the system was approximately 2.5 mI. The flow cell/quartz prism assembly was 
mounted flat against the aperture of the emission monochromator. 
Transmission spectra were also taken of the proteins in the presence and 
absence of concentrations ranging from 5 x 10-2 to 5 x 10-6 :tvf PEO in order to 
determine the occurance of fluorescence quenching by the PEO. This was done 
by focusing the incident beam perpendicular to a 1 cm path length cell and 
collecting at rightangles as previously described. 
The flowing experiments consisted of manually injecting a series of 
tryptophan solutions, of varying concentrations, into the flow cell and measuring 
the fluorescence emission. This was followed by a phosphate buffered saline 
(PBS) flush, after which the fluorescence was again measured. Tryptophan has 
been shown not to adsorb to clean quartz surfaces and was used as an external 
standard to quantitate the experiments. Following the wash out of the 
tryptophan solution, which was monitored by a return of the signal to background 
levels, a 0 .. 25 mg/ml solution of A T-m in PBS was injected. The concentration of 
the protein solutions was determined by UV absorbance using 6.5 ml mg-1 cm-1 
for the extinction coefficient. The initial flow rate was 15 ml/minute for 1 
minute in order to fully fill the flow cell and to minimize diffusion problems. 
After the first minute, a reduced flow of 1 ml/minute was continued for 1 hour. 
During the first 10 minutes of adsorption, the signal was counted for 1 second 
intervals. After the first 10 minutes an excitation shutter was closed to 
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reduce any UV degradation of the protein and opened only to obtain several 1 
second counts at 5 minute intervals. At the end of the 1 hour adsorption period, 
the signal was measured and a 20 ml bolus injection of PBS was used to flush out 
the bulk volume. PBS was then allowed to flow at 1 ml/min for 30 minutes after 
which the signal was recorded. It was found that after 30 minutes the decrease 
of the adsorbed protein signal was minimal. Following this, a 0.50 mg/ml 
solution of AT-m in PBS was similarly injected and allowed to adsorb for 1 hour. 
A buffer flush followed and signals recorded. The next step was the adsorption 
of a 1:10 dilution of a pooled human plasma (12 donors) in an identical flow 
scheme. Similarly a buffer flush terminated the adsorption after 1 hour. This 
adsorption scheme, shown schematically in Fig. 13, was used for clean, APS, 
PED, and PED /heparin surfaces. Spectral scans were taken from 270 to 400 nm 
in an attempt to see any conformational changes which may have occurred. 
2.8.2 125Iodine Protein Adsorption 
All protein solution concentration values were verified by UV absorbance 
{model 35, Beckman} using values for the extinction coefficient of 1.35 and 6.5 
ml mg-1 cm-1 for BSA and AT-III, respectively. The labeled protein was added 
to a known solution concentration of unlabeled protein immediately prior to the 
adsorption. For the BSA adsorption, the total concentration was 1.0 mg/ml with 
the ratio of unlabelled to labelled protein of 84:1. A 0.36 mg/ml solution of A T-
ID was used due to the small amount of AT-m available. The labelling ratio was 
58:1. 
Quartz chips (I x 2.5 x 0.1 cm, area of 5.7 cm 2), prepared as described in 
Section 2.2.1, were used for direct counting by a gamma well counter.. The chips 
were immersed into 2 ml of the protein solution in a 12 x 25 mm test tube and 















Figure 13. The adsorption scheme used for TIRF protein adsorption studies. 
Tryptophan standards were followed by successively increasing concentrations of 




withdrawn, rinsed by placing them into a clean test tube and adding 5 x 2 ml 
PBS, again transferred to another clean test tube, and again rinsed five times 
with 2 ml PBS each. The chips were then placed into capped scintillation vials 
and counted on a well gamma counter for 1 minute. Each tube was counted 
twice and the average of the two counts recorded. In addition, 100 ul aliquots of 
the protein solutions were reserved after the adsorption and counted to 
determine if any significant solution depletion had occurred. All surfaces were 
tested in triplicate. 
2.9 Stability Studies in Aqueous Buffer 
The stability of the APS and PEO surfaces was determined by soaking them 
in a phosphate buffered saline solution for various periods of time and analyzing 
for the elemental content by XPS. This was done by placing them into staining 
jars with PBS (pH 7.4 with 0.01 percent sodium azide as a bacteriocide) and 
allowing them to soak without stirring. The PBS was changed daily. At times 
ranging from 1 to 72 hours, slides were removed, washed three times with 
distilled water, ethanol and methylene chloride for drying, and stored under 
vacuum until analysis was performed. Surfaces tested were from at least three 
different reaction sets, with n being the number of different reactions tested. 
Controls for these studies consisted of clean quartz slides and APS coupled 
slides. APS slides were underivatized PEO physically adsorbed under identical 
conditions as were used for the covalent coupling were also analyzed to 
determine the stability of nonspecifically bound PEO. 
The surface elemental composition was analyzed by XPS using the cabon 
IS, oxygen IS, nitrogen IS, silicon 2S, and sulfur 2P were taken and normalized 
by their Scofield cross sections. Plots of the percent of ether carbon, carbon to 
62 
silicon ratio and sulfur content (in the case of the slides reacted with heparin) 
versus time were recorded. 
2.10 Heparin Activity Testing 
2.10.1 Whole Blood Clotting Times 
The anticoagulant activities of the del'ivatized glass beads prepared as 
described in Sections 2.3 and 2.4 were determined using a modification of the 
Lee White Whole Blood Clotting Test. (131) This test is by nature only a crude 
measure of coagulation activation and was used for screening which surfaces 
would be tested further for materials interactions. 
Glass tubes (12 x 50 mm Fisher Scientific) were prepared for this test by 
silanizing them using the method described in Section 2.2.2 and reacting them 
overnight, under nitrogen, with a 1 percent solution of PED-bis chloroformate 
MW 18,000 in methylene chloride. They were washed extensively with distilled 
water prior to ·use. Eighty mg "ofderivati.zed 'beads (calculated surface area of 
66 cm 2) were added to each tube and equilibrated with 2 ml of PBS solution for 2 
hours prior to the test. Immediately prior to the addition of blood, the PBS was 
withdrawn from the tubes using a glass pipet. 
Blood was collected from the author using the double syringe technique and 
used within 10 seconds of drawing. Using a stop watch to record time, 1 ml of 
whole blood was added to each tube and stirred with a glass pipet to mix the 
beads thoroughly with the blood. Three tubes were used for each sample. At 15 
second intervals the tubes were inverted in the same order each time, until a 
clot could be detected and the blood would no longer flow by inverting the tube. 
Time to clot was recorded for each sample and the time of clotting of the third 
tube of each sample was used according to protocol of the Lee-White method. 
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This test was performed on blood drawn at six different times and the results of 
these six tests averaged. 
During the first test, the blood in contact with beads containing the 
heparin failed to clot even after Z hours. The blood of these tubes was placed 
into tubes containing 80 mg of clean beads to determine if heparin had leached 
from the beads. After 3 hours, the blood still had not clotted and it was 
determined that more extensive washing of the heparin coupled beads was 
necessary. As a result, during succeeding tests, all heparin surfaces were soaked 
in buffer for at least Z hours and rinsed with distilled water three times before 
equilibration with PBS for the test. This seems to have been sufficient to 
remove all leachable heparin as subsequent testing of these surfaces caused 
clotting of the whole blood within Z hours of contact. 
Z.10.Z Activated Partial Thromboplastin Time Test 
The surfaces tested using the Activated Partial Thromboplastin Time Test 
(APTT) (132..) were chosen from the results of the Whole Blood Clotting Test. 
These were the PEO-bis chloroformate 18,000 and the PEO-bis isothiocyanate 
18,000 with and without heparin and the appropriate controls of clean glass and 
APS reacted glass. Blood from the author was collected using the double syringe 
method into 3.8 percent sodium citrate (nine parts blood to one part citrate) and 
centrifuged to prepare a platelet rich plasma (PRP). The supernatant plasma 
was collected and stored at 4 0 C until testing, but no longer than Z hours after 
drawing. 
APTT tests were conducted by first incubating various quantities of the 
derivatized beads with Z ml of the prepared plasma at room temperature for 30 
minutes, stirring every 5 minutes with a glass pipet. Plasma, with known unit 
activities of heparin, was prepared for generation of calibration curves. One 
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hundred ul of the plasma exposed to the beads, or plasma containing known unit 
activities of heparin were withdrawn and incubated with 100 ul of activated 
thromboplastin reagent (Ortho Pharmaceutics) at 370C for 5 minutes. One 
hundred ul of 0.3 M CaCIZ in distilled water was then rapidly added to the 
incubated plasma and clotting times were determined with a fibrometer 
(Beckman). A plot of APTT (seconds) versus heparin activity in the plasma 
(units/mI) was first prepared with plasma heparinized in 0.1 unit/ml increments. 
A linear relationship is typically observed between 0.0 and 0.5 units/ml of 
heparin. Unheparinized plasma was evaluated before and after all samples were 
run to ensure that coagulation factors had not degraded during the course of 
testing. Each plasma sample was tested for APTT in triplicate for each of two 
batches of plasma drawn at different times. The APTTs of plasmas exposed to 
the beads were compared to the calibration plot of known heparin unit activities 
and the activities of the plasma exposed to the derivatized beads determined in 
units/ml plasma. 
Z.ll Platelet Interactions 
Heparin has been reported to inhibit, (133, 134) enhance, (135, 136) and 
have no effect at all upon platelet function. {137} Due to both the heterogeneous 
nature of heparin preparations and the numerous methods of testing platelet 
adhesion, aggregation and activation, the precise effect of heparin is difficult to 
discern. Nevertheless, it appears that heparin potentiates platelet adhesion. 
Because platelets behave differently whe.n in the presence of other cellular 
material than in plasma, or after washing ana resuspending, retention tests were 
done using whole blood and platelet rich plasma. Platelet activation was 
measured using the release of Platelet Factor 4 from the ttl.. granules. 
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2.11.1 Platelet Retention 
Platelet retention by the various surfaces was measured by exposing whole 
blood or platelet rich plasma (PRP) to derivatized beads as a function of contact 
time and counting the platelets left in the fluid. The tubes were previously 
coated with PED-bis chloroformate (MW 18,000) as described in Section 2.10.1-
Eighty mg of beads were added to each tube and equilibrated with PBS for 2 
hours. The PBS was withdrawn with a glass pipet immediately before adding 
either whole blood or PRP. Whole blood was collected from the author using the 
double syringe technique into 3.8 percent sodium citrate (nine parts blood to one 
part citrate) and used either as is, or PRP was prepared by centrifugation. The 
supernatant plasma was collected and pooled for subsequent platelet testing. In 
the first series of tests, 2 ml whole blood were added to the tubes containing the 
derivatized beads, stirred gently with a glass pipet, and incubated for times 
ranging from 0 to 30 minutes at 37oC. The tubes were stirred every 5 minutes. 
The whole blood was then withdrawn and spun for 15 minutes at 2500 g and the 
plasma separated from the cells. This plasma was then counted for platelets in a 
Coulter Counter. In the second series of experiments, 2 ml PRP was incubated 
with the derivatized beads for various time periods and counted. This was done 
to determine if the presence of other cellular material had any effect on the 
behavior of platelets exposed to the surfaces. Controls consisted of blood or 
PRP which was incubated in the PED tubes with clean glass beads, without any 
beads, and with APS derivatized beads. A plot of exposure time versus number 
of platelets was determined for each of the surfaces exposed to whole blood and 
PRP. All surfaces were tested in triplicate from each of two batches of blood 
and averages determined. 
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2.11.2 Platelet Factor 4 Release 
Platelet Factor 4 levels in collected plasma exposed to the derivatized 
beads were determined by bovine PF4 R!A reagents (Abbott Laboratories). The 
test is a competitive radioimmunoassay in which nonradioactive PF4 in plasma, 
and buffer, competes with a constant amount of 125!_PF4 for binding sites in a 
constant, limited amount of bovine PF4 antiserum. The percentage of 
radioactive PF4 bound to the antiserum is therefore inversely proportional to the 
concentration of nonlabeled PF4 in the test samples. Again, tubes for these 
experiments were prepared with PEO-bis chloroform ate (MW 18,000) as 
described above. Eighty mg of derivatized beads were pre-equilibrated with 
PBS, then exposed to 1 ml of plasma for 30 minutes at 37oC. Fifty ul of dilution 
buffer, nonlabled bovine PF4 standards (in concentrations ranging from 50 ng/ml 
to 1000 ng/ml), or 50 ul of the plasma which had been exposed to the derivatized 
beads were added to 250 ul of the 125!-PF4 solution. Two hundred fifty ul of 
PF4 antiserum were added and the tubes incubated at room temperature for 2 
hours after which 1 ml of 73 percent saturated ammonium sulfate was added. 
The tubes were then incubated between 10 and 60 minutes and centrifuged at 
1500 g for 20 minutes. The supernatant was carefully decanted and the excess 
supernatant on the rim of each tube was blotted with tissue paper. The total 
125!odine in the precipitate was then counted with a gamma counter. The 
percent bound, expressed as cpm in 250 ul of the 125!-PF4 solution multiplied by 
100, was determined for each tube. A standard curve was prepared by plotting 
percent bound versus standard PF4 concentrations. By locating percent bound of 
the unknown test sample on the standard curve, the concentration of PF4 in the 




3.1 APS Coupling to Quartz Plates and Beads 
3.1.1 XPS Characterization of Surface 
The vapor phase silanized quartz substrates were characterized using XPS 
by monitoring the nitrogen and silicon signals. Generally, an atomic percentage 
of nitrogen in the range of 5.5 to 8 percent before hydration in PBS was 
considered to be complete surface coverage. Surfaces falling outside of this 
range were not used. The percents of nitrogen, carbon, silicon, and oxygen were 
plotted as function of soaking time in PBS buffer to determine the stability of 
the APS surface (Fig. 14). After soaking in PBS, the nitrogen IS signal appears 
as a split doublet at 394.8 and 393.1 ev which are presumably due to the presence 
of NHZ and NH3+ (Fig. 15). The area of both of these peaks was combined as the 
total nitrogen signal. As can be seen in Fig. 14, the nitrogen signal decreased 
slightly in the first hour, and then remained fairly constant after that time with 
a final value of 5 percent. This is also reflected by the constant value of the 
silicon signal during the period of hydration. Each point on the graph represents 
a minimum of four samples. The elemental percentages found on the clean 
quartz controls are, as would be expected, significantly lower (Fig. 16). An 
alternate method of analyzing these data is to plot the ratio of the nitrogen 
signal of the APS layer to the silicon signal arising from the quartz substrate. 
However, each molecule of APS has a single atom of silicon which contributes to 
the overall silicon signal. This must then be subtracted from the total silicon 
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APS Hydration Study in PBS 
5 Carbon 15 
~ -. • 0 
• Co) 0 0 0 








1 Nitrogen 15 ~.-. • • • 
0 
0 10 20 30 40 50 60 70 80 
Time I Hrs. 
Figure 14. The XPS elemental analysis of quartz surfaces derivatized with r -
aminopropyltriethoxy silane following exposure to PBS for various times. 
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Figure 15. The XPS spectrum of the nitrogen 1 S signal of APS-coupled quartz 
slides following exposure to PBS. The doublet presumably is due to the presence 
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Figure 16. The XPS elemental analysis of c]ean quartz slides following exposure 
to PBS for various times. 
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percentage. Assuming three attachment sites for each APS molecule, an atomic 
ratio for a multilayer of APS and quartz is N:Si:C:O of 1:1:3:1.5 and 0:1:0:2, 
respectively. The NISi ratios of the APS and clean quartz controls are plotted in 
Fig. 17. 
3.1.2 Variable Angle Thickness 
Variable angle XPS was used to estimate the thickness and homogeneity of 
the APS layer on the quartz substrates. This technique allows a calculation of 
the thickness or the percent coverage of an overlayer on a substrate. According 
to the equation for a uniform over layer: 
(7) 
where 
Ia is the integrated area of the substrate (in this case the 2S peak of 
silicon) 
Ib is the integrated area of the overlayer (in this case the IS peak of 
nitrogen of the APS) 
Aa is the mean free path of the silicon 2S electron (calculated by the 
Ashley method (125) to be 35.1A) 
A b is the mean free path of the nitrogen 1 S electron (calculated by the 
Ashley method (125) to be 43.7 A) 
e is the photoelectron take off angle. 
Using equation (7) above, a uniform overlayer of various thicknesses yields 
the curves seen in Fig. 18. The astericks on the graph represent the actual data 
obtained in this experiment and do not fit well with any of the curves. For this 
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Figure 17. The ratio of the nitrogen to silicon XPS signals of APS and clean 
quartz control surfaces following exposure to PBS for various times. 
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Figure 18. Plot of the equation for a theoretical uniform overlayer of APS on 
quartz of various thicknesses. The astericks (*) indicate actual data obtained in 
variable angle XPS experiments. 
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reason, modeling of the surface with a patchy over layer was done using various 
thicknesses for "t" in the equation: 
Ib = r Ab 1-exp(-5bl Ab sinEr) (8) 
Ia (1-,) "a + ()\a exp(-tbl .Ab sinO) 
where 
'(is the fraction of the surface covered by the overlayer and other symbols 
are as defined in equation (7). 
An overlayer thickness of 10, 20 and 50 ! yields the curves expressed in 
Figs. 19-21. The fractional surface coverage is given by the different curves. 
The astericks plotted on the graph are the actual data obtained at take off 
angles from 4 0 to 85 O. Using a least squares best fit, the data correspond most 
• closely to an overlayer of 50 A of APS on the quartz substrate and 50 percent 
coverage. This is contrary to popular belief that vapor phase silanization using 
this method creates a homogeneous monolayer; however, each asterick on the 
graph represents three samples, each silanized in separate reactions. The error 
in these experiments was no greater than plus or minus 10 percent of the area of 
the atomic signals. 
3.1.3 Wilhelmy Plate Characterization 
The measured contact angles on the APS silanized slides after soaking in 
PBS for various periods of time are shown in Fig. 22. As can be seen in the 
figure, clean glass with no previous soaking in PBS produced a 00 contact angle 
with no hysterisis. After exposure to PBS, the contact angle increased to 10.7 .:. 
2.30 for the advancing angle and 4.5 .:. 1.70 for the receding angle over the test 
period of 72 hours. This is presumably due to contamination of the PBS during 
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Figure 19. Plot of the equation for a theoretical 10 A patchy overlayer of APS 
on quartz for varying surface coverages ( r). The astericks (*) indicate actual 
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Figure 20. Plot of the equation for a theoretical 30 A patchy overlayer of APS 
on quartz for varying surface coverages ( K). The astericks (*) indicate actual 
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Figure 2.1. Plot of the equation for a theoretical 50 A patchy overlayer of APS 
on quartz for varying surface coverages (t). The astericks (*) indicate actual 
data obtained in variable angle XPS experiments. 
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Figure ZZ. The contact angles of clean and APS derivatized quartz measured by 




quartz. The APS contact angles were also found to vary over the time of 
hydration. Before hydration, the angles were very reproducible yielding values 
of 43.5 + 2.1 0 and 11.8 .:!:. 1.70 for the advancing and receding angles, 
respectively. This represents five separate reactions of vapor phase silanization 
with triplicates of each reaction" However, over the course of hydration, the 
angles were found to vary significantly as can be seen in the figure and the large 
standard deviations of + 100. Following hydration, the advancing angle was 
found to be 30.9 + 12.80 and the receding angle of 8.1 .:t 5.60• This was not 
reflected in the results of the XPS characterization as discussed above. 
As a side study, the stability of the APS layer following exposure to 
different buffers and ionic strengths was analyzed. Soaking in borax pH 9.7 and 
ionic strength of 0.2.0 for only 4 hours produced 61.40 and 8.10 for the advancing 
and receding angles, respectively. Similarly, exposure to an acetate buffer of pH 
3.7 and ionic strength of 0.19 produced advancing and receding angles of 53.00 
and 16.30, respectively. For both of these buffers, the angles were found to be 
unstable following the second pass into the contact angle water, indicating the 
APS had probably come off into the water. This presumably resulted in a change 
of the surface tension of the water, thus invalidating the measurements. 
3.2 Poly(ethylene oxide) Coupling 
to Quartz Plates and Beads 
3.2.1 XPS Characterization of Surface 
All surfaces were XPS analyzed for PED coverage following the coupling 
reactions by monitoring the carbon 1S, oxygen IS, nitrogen IS, silicon 2.S, and 
sulfur 2.P signals. Fig. 23a shows a carbon IS XPS spectrum of pure PED (MW 
6,000). The peak at 2.85.6 ev (charge referenced to CIS, 284.0) corresponds with 
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Figure 23. The carbon IS XPS spectra of surfaces analyzed. a) pure PEO; b) 




in PEO are equivalent. The carbon 1 S spectrum of Fig. 2.3b shows the aliphatic 
carbon peak of an APS silanized quartz slide with the peak at 2.84.0 eVe Fig. 2.3c 
is again the carbon IS spectrum; this time it is a spectrum of a quartz slide to 
which PEO has been bound via the APS coupling agent. The aliphatic carbon of 
the APS layer is evident as a distinct shoulder on the lower binding energy side 
of the other carbon peak. It is the ether carbon component of the total carbon 
I S spectrum which has been used to monitor the stability of the PEO on the 
surface. This can be seen in the curve resolved carbon IS spectrum of Fig. 2.4. 
Figs. 2.5-32. show the elemental percentages of the four derivatives for the 
two molecular weights used in this study after various times of hydration in PBS 
buffer. The carbon signal plotted in these graphs is the total carbon detected on 
the surface and therefore also reflects the carbon component of the attached 
APS. The same data of the control, a clean quartz slide, were seen in Fig. 17. 
It is perhaps more beneficial to compare the percent of the total carbon 
signal due to the ether carbon component. It is the ether carbon signal which 
reflects the amount of PEO on the surface. Fig. 33 is the ether carbon signal of 
the control surfaces to which underivatized PEO was physically adsorbed. From 
Figs. 33 and 34, it is apparent that some of this adsorbed PEO remained on the 
APS surface after the rinse but prior to the hydration in PBS. The slightly higher 
initial C/Si ratio of 3.0 and the ether carbon content of 32. percent are higher 
than the same values of the clean quartz control surfaces. The adsorbed PEO 
partially desorbed during the three day PBS soak as reflected by the slight 
decrease of these curves with time. Final parameters for the APS controls were 
C/Si of Z.O and 2..3 for the molecular weights 6,000 and 18,000, respectively. 
Final values for the ether carbon content are 2.2. percent for MW 6,000 and 18 
percent MW 18,000. 
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CARBON 15 
Figure 24. The curve-resolved carbon 15 spectrum of PEO immobilized on 
quartz via AP5 coupling agent. It is the ether carbon component of the carbon 
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Figure 25. The total XPS elemental signals of PEO-bis chloroformate MW 6,000 
immobilized onto a quartz slide as a function of hydration time in PBS. 
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Figure 2.6. The total XPS elemental signals of PEO-bis thiochloroformate MW 
6,000 immobilized onto a quartz slide as a function of hydration time in PBS. 
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Figure 27. The total XPS elemental signals of PEO-bis isocyanate MW 6,000 
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Figure '28. The total XPS elemental signals of PEO-bis isothiocyanate MW 6,000 
immobilized onto a quartz slide as a function of hydration time in PBS. 
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Figure 29. The total XPS elemental signals of PED-bis chloroformate MW 18,000 
immobilized onto a quartz slide as a function of hydration time in PBS. 
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Figure 30. The total XPS elemental signals of PEO-bis thiochloroformate MW 
18,000 immobilized onto a quartz slide as a function of hydration time in PBS. 
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Figure 31. The total XPS elemental signals of PED-bis isocyanate MW 18,000 
immobilized onto a quartz slide as a function of hydration time in PBS. 
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Figure 32. The total XPS elemental signals of PEO-bis isothiocyanate MW 
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Figure 33. The percent of the total carbon XPS signal due to the ether carbon 
component of the control surfaces. The underivatized PEO was physically 
adsorbed to the APS/quarts surfaces and slowly leached from the surface. 
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Figure 34. The carbon to silicon ratio of the XPS elemental analysis of control 
surfaces as a function of hydration time in PBS. 
Q3 
The ether carbon contents of four MVI 6,000 PED derivatives are expressed 
in Fig. 35. The CISi ratios of these same four derivatized surfaces are plotted in 
Fig. 36. What is most striking about both these graphs is the very high degree of 
coupling of the PED chloroform ate and thiochloroformate derivatives, which 
initially have an average ether carbon content of 70 percent for the 
chloroformate and 78 percent for the thiochloroformate. This is indicative of a 
surface very rich in PED. However, the PEO layer resulting from these two 
derivatives appears to be somewhat less stable than the isocyanate and 
isothiocyanate derivatives. This is reflected by the decrease to a final value of 
approximately 32 percent ether carbon, a CISi ratio of 3.4, for the 
thiochloroformate, ether carbon of 30 percent, and CISi of 3.0 for the 
chloroformate derivative. 
Similar trends, although less dramatic, are observed in the 18,000 
molecular weight derivatives seen in Fig. 37. The decrease in the initial values 
for ether carbon of 69 percent and 72 percent for the chloroformate and 
thiochloroformate of 44 percent and 50 percent again tend to indicate less 
stability of the urethane linkages involved in the chloroformate reactions. 
The two cyanate derivatives of both molecular weights have a lower degree 
of PEO coupling than the chloroformates. This is based on an initial average 
ether carbon content of 65 percent and 58 percent for the 6,000 isocyanate and 
isothiocyanate, respectively, and 53 percent and 49 percent for the 18,000 
molecular weight isocyanate and isothiocyanate derivatives, respectively. These 
appear more stable over the 3 day hydration period. Final values for the ether 
carbon content of the cyanate derivatives are: 40 percent for isocyanate 6,000; 
45 percent for isothiocyanate MW 6,000; 53 percent for the isocyanate MW 
18,000 and 49 percent for the isothiocyanate MW 18,000. 
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Figure 35. The percent of the total carbon XPS signal due to the ether carbon 
component of the four PEO derivatized surfaces MW 6,000 as a function of PBS 
exposure time. 
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Figure 36. The carbon to silicon ratio of the XPS elemental analysis of the four 
PED derivatized surfaces MW 6,000 as a function of PBS exposure time. 
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Figure 37. The percent of the total carbon XPS signal due to the ether carbon 
component of the four PEO derivatized surfaces MW 18,000 as a function of PBS 
exposure time. 
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Again, this is reflected in the C/Si ratios for the cyanate derivatives seen 
in Figs. 36 and 38. The values of 3.8 and 4.0 for the MW 6,000 derivatives 
compare similarly with the 4.5 and 4.0 for the 18,000 MW derivatives. 
The quartz beads were similarly XPS characterized; however, less 
extensive testing was performed, to demonstrate the stability of the PEO 
coatings. Table n summarizes the results of a single study, involving triplicate 
samples for each case. As mentioned in Section 2.2.1, the beads were pressed 
into indium foil for analysis in the spectrometer. Although indium was detected 
in the scans, any hydrocarbon contamination on the foil did not enter into the 
elemental percentages for the PE~. This was conveniently avoided due to the 
lack of conductivity of the glass beads leading the peaks to be charge shifted to 
lower binding energies. Distinct peaks of elements coming from the indium were 
discernable as can be seen in the carbon IS spectrum seen in Fig. 39. The small 
peak at 284.2 ev is presumably hydrocarbon contamination on the indium foil. 
3.2.2 Variable Angle XPS Thickness 
Variable angle XPS analysis, modeling the thickness and homogeneity of 
the PEO layer, was performed using isocyanate derivatives of 6,000 and 18,000 
molecular weights. In this case, the APS and PEO were assumed to be a 
homogeneous overlayer. Data were calculated according to the equations given 
above using A for the carbon IS peak of PEO of 30.8 A and 35.1 A for the 
silicon 2S peak of the quartz substrate. The results of these calculations for 
uniform and patchy over layers of various thicknesses were plotted and the best 
fit graph is shown in Fig. 40. The actual values obtained for the 6,000 MW are 
represented by the astericks on the graphs. Only the ether carbon component of 
the total carbon signal was used in these calculations. Again, a least squares 
analysis of the data indicates that the PEO overlayer fits most closely with the 
Table n 
Elemental Analysis of PEO Stability 
on Glass Beads 
Time C 0 N Si 
1 51 36 2 1 1 
8 47 37 2 14 
24 43 37 2 15 
48 42 36 2 14 
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Figure 38. The carbon to silicon ratio of the XPS elemental analysis of the four 
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Figure 39. The carbon 1 S spectrum of PED derivatized glass beads. The small 
peak at 284 ev is the hydrocarbon contamination of the indium foil on which the 
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Figure 40. Plot of the equation for a theoretical 70 X patchy overlayer of PEO 
on APS derivatized quartz for varying surface coverages ( r). The astericks (*) 





equation of a patchy 70 A thick overlayer with 80 percent surface coverage. 
There was little detectable difference in the 6,000 and 18,000 molecular weights. 
This is presumably due to the collapsed nature of the polymer layer in the 
vacuum of the XPS spectrometer and will be discussed further in Section 4.1. 
3.3 Heparin Coupling to Quartz Plates and Beads 
3.3.1 XPS Stability Characterization of Surfaces 
The heparin coupled surfaces were XPS analyzed for carbon IS, oxygen IS, 
nitrogen IS, silicon ZS, and sulfur ZP. Pure as received heparin was compared 
with the heparin coupled surfaces. Table m shows the elemental analysis of the 
pure heparin powder and heparin immobilized via PED-bis chloroformate and 
PED-bis thiochloroformate (MW 3,400). The sulfur content of the pure heparin 
was found to be 6.9 percent. If the sulfur content is calculated by atomic ratios 
from the known heparin structure, this compares favorably with expected values. 
Df course, the sulfur content cannot be calculated exactly as a result of the 
heterogeneous nature of the heparin structure. If the PED derivativized slides 
contained a thick homogeneous layer of heparin, the sulfur content should be 
about 7 percent. It will be remembered that XPS scans the top 50 It of the 
surface, and since there is silicon detected from the substrate, it may be 
concluded that either the layer of PED/beparin is less than this thickness or 
there is incomplete surface coverage by the overlayer. This will be discussed in 
the next section. 
The sulfur ZP signal shown in Fig. 41 was used to monitor the stability of 
the heparin on the surface following exposure to PBS. The top spectrum is the 
sulfur ZP peak of pure heparin. The lower spectrum is immobilized heparin on a 
PED-bis isothiocyanate spacer. The peak at 16Z.5 ev binding energy of the lower 
spectrum is the charge shifted ZP sulfur peak of heparin. The high resolution of 
Table m 
Elemental Content of Heparin and 
Heparin Derivatized PED 
Surfaces (MW 3,000) 
DESCRIPTION' C 0 H Si S 
Na-heparin 
powder 45.5 45.3 2.5 0 6.9 
PEO-OCl 
+ heparin 55.1 34.3 4.6 2.2 3.7 















Figure 41. The sulfur ZP XPS signal from heparin. a) pure heparin powder; and 
b) heparin immobilized via PEO-bis isothiocyanate. The sulfur of the 
isothiocyanate is charge shifted enabling differentiation of the sulfur of heparin. 
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these spectra enables the sulfur 2.P of the isothiocyanate PEO to be 
differentiated from the sulfur 2.P of the heparin due to the less electronegative 
environment of the PEO alkyl sulfur. Only that portion of the sulfur 2.P peak due 
to the heparin was used in the calculations. 
Fig. 42. shows the sulfur content of the four MW 6,000 derivatized surfaces 
as a function of time. The clean quartz controls and a PEO-bis isothiocyanate 
derivatized slide without heparin are also plotted for comparison. The initial 
decrease in the sulfur signal indicates the heparin, like the PEO surfaces, was 
probably incompletely rinsed, resulting in unbound heparin on the surface. Over 
the 3 days tested, the heparin did not continue to leach from the surface after 
the initial loss. 
The sulfur content of the cyanate derivatives was constantly higher after 
the 3 day soak than that of the chloroform ate derivatives. This may not be 
statistically significant based on the margin of error of 10 percent for these 
data, but apparently the chloroformate/heparin derivatives are slightly less 
stable than the cyanate derivatives. 
Fig. 43 shows the results of heparin coupling stability of the 18,000 MW 
derivatives. Again, after an initial loss from the surface, the sulfur content 
remains stable for a period of 3 days. This indicates a surface rich in heparin. 
The chloroform ate derivatives appeared slightly less stable than the cyanate 
derivatives, as was true for the lower molecular weight surfaces. The clean 
quartz controls also appear on the graph. Data from the surface to which 
underivatized PEO was physically adsorbed, then reacted with heparin also 
appear on this graph .. There is some binding of the heparin to this surface as can 
be seen by the 1.5 percent sulfur content. Presumably, this is bound via the free 
amine groups of the APS which would be expected to bind with the carboxylic 
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Figure 42. The sulfur 2P XPS signal of the four PEO/heparin surfaces MW 6,000 
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Figure 43. The sulfur ZP XPS signal of the four PEO/heparin surfaces MW 18,000 





resistance properties the PEO affords. This also involves blocking the heparin 
carboxylic groups which are necessary for activity. 
3.3.2 Variable Angle XPS Thickness 
Two different molecular weights of the PEOs with immobilized heparin 
were analyzed by variable angle XPS. The value used in the calculations for the 
mean free path (A) of the sulfur ZP electron was 34.9 1, while the photoelectron 
take off angle was varied from 40 to 800 • The calculations assumed the 
overlayer (APS, PEO and heparin) was homogeneous. The data were plotted on 
graphs of a patchy overlayer model of thicknesses from 70 A to 100 l. The 
assumption is not strictly valid but can be justified by the organic nature of the 
over layer as opposed to the silicon substrate. This approach produced a large 
scatter in the data, presumably due to the small sulfur signal arising only from 
the heparin. Therefore, the intensity of the total carbon signal was used to 
account for the APS, PEO and heparin layers. The data were replotted using 
30.S A for A of the overlayer and fit to the curves modeling a patchy overlayer 
of 90 A (Fig. 44) with 95 percent coverage. Considering the collapsed nature of 
the overlayer under the strong vacuum of the XPS spectrometer, this probably 
has little relevance to the thickness of the PEO /heparin layer in solution, where 
it is free to extend out from the surface with considerable mobility. It may be 
that if only 80 percent of the surface has grafted PEO, the heparin, while 
attached to one end of the PEO chain, actually lies collapsed in the "valleys" 
between the "mountains" of PE~. Perhaps more relevant is the concentration of 
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Figure 44. Plot of the equation for a theoretical 90 A patchy overlayer of 
heparin on PEO coupled quartz surfaces for varying surface coverages ( ~). The 
astericks (*) indicate actual data obtained in variable angle XPS experiments. 
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3.3.3 Quantitation 
XPS is only relatively quantitative; therefore, for absolute quantitation the 
amount of hepat'in on the surface was measured using tritium labeled heparin. 
The dpm of the three replicates for each sample with known weights of beads 
were averaged and the amount of heparin calculated. Two different calculations 
were completed. In the first, the dpm/mg of beads were calculated, averaged 
for all five amounts of each molecular weight, and divided by the specific 
activity of the heparin to yield the amount of heparin per mg of beads. The 
second calculation used the surface area of the beads of each sample, calculated 
by the known weight and the density (2.0 g/cm3) to obtain ug/cm2. 
The five weights of beads used for the 6,000 molecular weight derivatives 
averaged 53.9 .:!: 6.5 dpm/mg of beads. The 18,000 molecular weight derivatized 
surfaces were slightly less than this: 42.3 .:!: 5.1 dpm/mg of beads. One possible 
explanation for this result, is that the heparin immobilization method requires a 
totally organic solvent system. Formamide is not a particularly good solvent for 
PEO which may have caused the PEO chains to collapse and coil among 
themselves, prohibiting the reactive end groups from coupling with the heparin. 
In the case of the 18,000 MW derivatives, increased chain length may translate 
to m ore densely coiled chains on the surface. 
Another possible explanation for the lower amount of heparin with longer 
chains, is that heparin may have multiple attachment sites; i.e., one molecule of 
heparin may be coupled with more than one PEO chain. This could result from 
the higher flexibility of the longer chains. 
Expressing the amount of heparin per unit surface area, the derivatives 
ranged from 1.159 to 0.945 ug/cm 2 and 0.936 to 0.672 ug/cm 2 for the 6,000 and 
18,000 molecular weight derivatives, respectively {Table IV}. All values are on 




















Quantitation of Surface Immobilized 
Tritia ted Heparin 
average su rl ace 
Surface dpm/mg bound beads rna/em 2 
Clean 1x10- 4 2.15x10- 6 
PEO-NCO 1x10- 4 2.15x10- 6 
18,000 
PEO-NCO 53.9 1.052 
6,000 
PEO-NCO 42.3 0.901 18,000 
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via other methods. However, comparison is difficult due to major differences in 
method of surface attachment, derivatization of the heparin prior to 
immobilization, and the substrate used. What is more important is the activity 
of the heparin expressed as an activity per unit surface area. It is this figure 
which expresses the usefulness of the surface. 
3.4 Protein Adsorption Studies 
3.4.1 Total Internal Relfection Fluorescence (TIRF) 
In order to test whether or not the intrinsic fluorescence of the protein was 
quenched by PEO, bulk transmission spectra were taken in the presence and 
absence of PEO ranging in concentration from 5 x 10-2 to 5 x 10-6 M. Fig. 45 
shows the results. The two most concentrated solutions of PEO attempted, 5 x 
10-2 and 2.5 x 10-2 M, caused precipitation of the protein. At 5 x 10-3 M PEO 
concentration, there was approximately a 15 percent reduction in the signal due 
to the presence of the PEO. This is very near the concentration required for 
precipitation of the protein. However, this is a bulk transmission experiment and 
extrapolation of these results to a surface on which the PEO is immobilized and 
protein near in solution assumes that the quantum yield of the protein does not 
change upon adsorption. This has been shown to be erroneous by Reinecke in the 
case of IgG adsorption to clean quartz. (138) For this reason, quantitation of the 
adsorbed protein was not attempted. Only relative comparisons of the TIRF 
signal can be made with any validity. 
Table V reports the fluorescent signal of the adsorbed protein on the 
surfaces of clean quartz, APS derivatized quartz, PEO-bis chloroformate (MW 
3,400) and a PEO derivatized surface to which heparin has been coupled. The top 
num ber of each group is the signal prior to the buffer flush and represents both 
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Protein Adsorption From Solution 
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arising strictly from protein adsorbed on the surface. All values have been 
corrected for background. This was a step isotherm experiment with solutions of 
higher concentration being adsorbed subsequently. As expected, the clean quartz 
control adsorbs protein from even the dilute solution of AT-m and adsorbs more 
from increasingly concentrated solutions. 
The APS derivatized surface shows anomalous behavior. During the 
adsorption of the tryptophan standards, the signal increased to the values given 
in the top of each box. Subsequent flushing with buffer did not bring the signal 
back to background levels. This is apparently due to binding of the free amine 
groups of the APS to the carboxylic groups of the tryptophan. Before standards 
were run, the background signal was 373. Following the standards, the 
background was 1127. Subtracting this from the signal following buffer flush, 
the corrected values for APS are 173, 323, and 2623 for the 0.25, 0.50 mg/ml 
AT-m and plasma, respectively. 
The PEO derivatized surface showed the least protein adsorption from all 
three solutions. 'While some adsorption was noted by the 134 value following 
adsorption of the diluted plasma, this can be considered negligible in reference 
to the control surfaces. These data represent the results of four different 
experiments for each surface. The standard deviation is given in parentheses. 
The heparin coated surfaces adsorbed slightly more protein than the PEO 
derivatized surfaces, but considerably less than either of the control surfaces. 
This follows the expected results that the heparin would bind the AT-ill; 
however, nonspecific adsorption of the heparinized surface would be minimized 
by the presence of the PEO. Plasma levels of AT-m in the normal human male 
are approximately 0.2 .! .05 mg/ml. This is approximately equal to the 
concentration of A T-m of the first step of this isotherm experiment. However, 
at the higher concentration of AT-ill used in the next step, slightly more protein 
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was adsorbed by the heparin surface. This would indicate that the surface bound 
heparin was not saturated by the less concentrated AT-III solution. 
Heparin is known to bind numerous other plasma proteins. This may 
account for the increase in the fluorescent signal following the diluted plasma 
adsoprtion. Still, this adsorption is nearly an order of magnitude less than either 
of the control surfaces indicating that the nonspecific adsorption seen on the 
other surfaces has been minimiz ed by the presence of the PED. 
3.4.Z 1 Z5I-Labeled Proteins 
The results of two bovine serum albumin adsorption experiments are given 
in Table VI. In the first experiment, the ratio of unlabeled to labeled protein was 
100:1, and for the second the ratio was 84:1. Each chip was individually 
measured for exact surface area, three chips of each derivative and molecular 
weight were counted. Two derivatives, PED-bis chloroformate and PED-bis 
isothiocyanate, were used being representative of the least and most stable of 
the four derivatives tested for aqueous stability. The amounts of BSA adsorbed 
on clean quartz and APS derivatized quarts agree with each other well and are 
not significantly different from values of IgG found on the same surfaces by 
Reinecke. (138) 
A11 four of the PED derivatized surfaces showed reduced adsorption by 
nearly a factor of 10 than either of the controls. Interestingly, there is a factor 
of two difference between the chloroformate derivatives of different molecular 
weights but not an appreciable difference for the cyanate derivatives. N agaoka, 
using varying lengths of PED as the soft segment of a block copolymer system, 
found that no difference in the protein adsorption characteristics could be 
detected aft-er n ~ 100. (9) For PED molecular weight 6,000, n = 135 units and 





Adsorbed lZ5I-Proteins Onto PEO 
and PEO /Heparin Surfaces 
BOVINE SERUM ALBUMIN HUMAN ANTITHROMBIN-III 
0.571 + 0.038 0.691 + O. 145 
0.379 + 0.051 0.429 + 0.125 
PEO- OH ( adsorbed) O. 296 + 0.067 0.312 + 0.045 
PEO-OCI 6, 000 0.073 + 0.011 0.127 + 0.015 
PEO-OCI 18,000 0.034 + 0.025 O. 091 + O. 025 
PEO- NCS 6,000 0.081 + 0.027 0.025 + 0.015 
PEO- NCS 18,000 0.062 + 0.033 O. 098 + O. 048 
PEO-OCI 6,000 0.084 + 0.012 0.857 + 0.015 
+ HEPARIN 
PEO-OCI 18,000 0.058 + 0.029 O. 593 + O. 048 
+ HEPARIN 
PEO- NCS 6,000 0.080 + 0.014 0.863 + 0.045 
+ HEPARIN 






observed results might be due to the difference in stability of the derivatives. 
This will be discussed in Section 4.2. 
The surfaces with the immobilized heparin did not adsorb more albumin 
than the PEO surfaces without heparin. This is as expected; albumin is not 
known to specifically bind heparin. 
The results of the single adsorption experiment using AT-m are also found 
in Table VI. Although triplicates of each surface were tested, only enough 
protein was available for adsorption from a single solution of AT-ill. Assuming 
the results of this single experiment are valid, all surfaces adsorbed more AT-TIl 
than albumin. The clean quartz adsorbed 0.69 ug/cm 2 as opposed to 0.57 ug/cm 2 
for albumin and the APS adsorbed 0.43 ug/cm 2 of AT-m and only 0.38 ug/cm 2 
albumin. All proteins are known to have different adsorption characteristics on 
diffexent surfaces which is one reason that blood materials interactions is such a 
complex field. !he PEO coupled surfaces, while exhibiting the same trends seen 
with the albumin adsorption, show considerably more adsorption of AT-m than 
albumin. Still, the amount of protein on these surfaces is less by a factor of 
three than the controls. However, no difference was found between the two 
molecular weights of PEO. 
An interesting finding of this experiment is the immobilized heparin 
surfaces adsorbed four times more A T-m than the PEO surfaces without heparin. 
This alone indicates that the heparin has retained at least some of the AT-m 
binding activity in the immobilized state. Apparently, the heparin 
immobilization procedure did not block the necessary AT-m lysine binding site. 
Quantitation of adsorbed protein by radiolabeling procedures is 
controversial. Conflicting results have been reported for preferential adsorption 
of labeled or unlabeled protein. Bornzin and Miller found no change in the 
adsorption of albumin on silicone rubber and Cuprophan or fibrinogen on silicone 
119 
rubber. (139) Horbett found similar results for fibrinogen, hemoglobin, albumin, 
and IgG on polyethylene. (140) However, Van Der Sheer showed significant 
alteration in the adsorption properties of human serum albumin on polystyrene 
latex. (141) In any case, preferential binding appears to be dependent on the 
surface, radionuclide, and the protein used and caution must be exercised when 
interpreting results. 
No tests were performed in this study to determine preferential binding of 
the labeled protein. The only conclusion that can be drawn is that these results 
support those seen in the TIRF experiments using unaltered protein. The PEO 
surfaces adsorb less total protein than the controls, and less than the heparinized 
surfaces in the case of the AT-m. 
3.5 'V'hole Blood Clotting Times 
The PEO derivatized surfaces, of both molecular weights, were tested for 
whole blood clotting times. This was done as a screen to determine which of the 
derivatives would be tested further for heparin activity. The results are shown 
in Table vn, where the number of triplicate tests run is indicated by n and the 
standard deviation is given in parentheses. As was mentioned previously, the 
heparinized surfaces initially failed to clot the blood and required more 
extensive washing procedures. The results in the table are those obtained 
following the extra rinsing procedures. 
The PEO surfaces without heparin produced a slight increase in clotting 
time over the controls, with both molecular weights averaging approximately 17 
minutes. There was no detectable difference in the two molecular weights or 
between any of the four derivatives. The surfaces with the immobilized heparin 
produced significant increases in the time required to clot the blood. The only 
difference between the four derivatives coupled with heparin was noted in the 
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Table vn 
Whole Blood Clotting Times 
Surface MW 18,000 MW 6,000 
Clean Glass 6 ( ~O. 9) ---
0=5 
APS Glass 17 ( ± 1. 5) ---
0=5 
PEO( adsorbed) 9 (%3.0) 8.5 ( ±2. 0) 
n=3 
PEO- OCI 18 ( ±4. 0) 16 (%3. 5) 
n=5 
PEO· SCI 12 ( i:3. 0) 17 (t3.0) 
0=5 
PEO- NCO 21 (:.t1.5) 17 ( :i3. 0) 
rF=7 
PEO - NCS 18 ( t2. 5) 21 ( i;2. 5) 
rF=7 
PEO OCI HEP 89 (:.t:5.5) 98 (:6. 0) 
rF=8 
PEO-SCI HEP 109 ( ±4. 0) 106 (:.t7. 0) 
rF=8 
PEO-NCO HEP 82 (:3.0) 78 (%5.0) 
rF=8 
PEO- NCS HEP 79 ( ±2. 0) 85 (±6.0) 
rF=8 
Beads first soaked in PBS for 72 hours pH 7.4: 
CLEAN 6.5 ( %1. 0) - - -
rl=3 
PEO- OCI HEP 69 (::1=4.5) - - -
n=5 
PEO- SCI HEP 87 (:t:5.0) - - -
n=5 
PEO-NCO HEP 53 ( i:6. 0) - - -
n=5 
PEO-NCS HEP 63 ( i:7. 5) - - -
n=5 
12.1 
thiochloroformate derivatized surface. No explanation for this is apparent 
except that the standard deviation of the eight tests run is larger for this 
sample. Again, there' was no detectable difference between the two PEO 
molecular weight s. 
In addition to the new rinsing procedures, beads exposed to PBS for 72. 
hours were also tested for clotting times in order to determine if there was loss 
of activity after this time period. A 2.5 percent decrease in the time to clot was 
observed. This loss of activity could have resulted from two sources: either 
there was leaching from the surface leading to a decrease in the amount of 
heparin available, or the heparin which was present lost activity due to 
degradation. Leaching of the surface bound heparin is unlikely based on the 
results of the radiolabeled and XPS stability analyses; however, degradation 
would not be expected to occur under these conditions. Heparin is a very stable 
molecule. 
The beads and tubes had a total surface area of approximately 66 cm 2.. 
Using the average amount of heparin of 0.75 ug/cm2. determined from the 
3H-labeled heparin, this translates to 3 mg total heparin in 1 ml of blood for 
each sample. 
3.6 Activated Partial Thromboplastin Times 
A standard curve was generated by using known amounts of heparin in 
plasma. Known weights of PEO derivatized beads were incubated with the same 
plasma used in the generation of the standard plot, and APTTs were determined. 
Since no detectable differences in the whole blood clotting time were observed 
between the two molecular weights, only the 18,000 MW derivatives were tested. 
From the standard curve, amounts of heparin per ml plasma were calculated. 
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The APTT of the various quantities of immobilized heparin beads is given 
in Fig. 46. The well washed heparin/PE~ beads demonstrated anticoagulant 
activity as shown by the prolonged APTT. The increase in clotting time was 
directly proportional to the amount of heparinized beads added to the plasma. 
PEO derivatized and clean beads without heparin had no significant effect on the 
clotting times. 
Activities of the immobilized heparin as determined by APTT tests and the 
average activity of heparin/mg (average of 1.05 ug/cm 2 and 0.90 ug/cm2 for the 
6,000 and 18,000 molecular weights, respectively) are presented in Table VITI. 
These data are averages of the various amounts of beads used to calculate 
activity. The standard deviations are given in parentheses. The control 
surfaces, the clean, APS and PEO derivatized beads without heparin were found 
to have less than 0.001 U/ml plasma. The heparin, as received, was reported to 
have an activity of 157 U/mg. Based on the APTT test, the bound heparin 
appeared to have approximately 25 percent of the activity of the comparable 
amount of heparin in solution. There appeared to be no significant differences in 
these values for the two derivatives or for the two molecular weights of PEO 
used. The 18,000 molecular weight derivatives, while having less immobilized 
heparin on the surface (dpm/mg beads), did not have less activity per mg of 
heparin as can be seen in the table. For this reason, it was important to report 
the activity of the heparin in U /mg heparin rather than in U /mg beads. 
The activity of these surfaces is significantly higher than that reported by 
Sefton using Diosynth heparin immobilized to poly(vinyl alcohol) beads. (142) 
However, he notes that the size of beads used had a large influence on the 
resultant activity; the smaller the beads the higher the activity observed. The 
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Figure 46. The Activated Partial Thromboplastin Times of various quantities of 










Activity of Immobilized Heparin 
Surfaces Determined by APTT 
HEPARIN CONC. 
(U I mJ plasmal HEPARIN ACTIVITY 
mg beads) (U I mg Heparin) 
3.3 x 10~2 39.4 ( + 3.6) 
- 2 2.64 x 10 37.9 (+ 4.9) 
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um and found to have only 0.26 percent activity. No reasons were suggested for 
this size/activity relationship. 
Ebert et ale found a difference in activities of immobilized heparins on 
diaminoalkane-agarose dependent upon chain length of the spacer for attachment 
and chemistries of immobilization reactions. (143) Prior to immobilization, 
Ebert et ale used various derivatization procedures with little loss of activity. 
While it is difficult to directly compare amounts of heparin on the surface 
because they report amount/cc swollen gel, the time to clot of the immobilized 
heparins was very similar to the results found here. 
3.7 Platelet Retention 
The retention of platelets by the derivatized surfaces was determined using 
both whole blood and platelet rich plasma (PRP) in order to see if the presence 
of other cellular material influenced the adsorption behavior of platelets. The 
platelets present in the plasma, following incubation with derivatized beads, 
were counted, normalized to the amount of heparin present and plotted as a 
function of time of incubation. Fig. 47 shows the results of typical curves 
generated in these experiments. 
A modification of Merrill and Salzman's mean platelet retention index (73) 
was developed in order to report a single value reflecting the adsorption behavior 
of platelets by these surfaces. The mean platelet retention index (p) is defined 
by: 
where: 
r = number of platelets at time t 
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Figure 47. A typical curve generated in the platelet retention studies using 





This convenient index premits the comparison of different surfaces 
regardless of the amount of time of exposure. Table IX reports the indices of 
retention found by all surfaces tested using both whole blood and PRP. Values 
were normalized to clean glass. All PED surfaces without heparin had values for 
the retention index significantly below those of the controls. All surfaces with 
immobilized PED/heparin complexes had an intermediate value between the 
controls and the PED without heparin. This indicates that there are virtually no 
platelets retained by the PED coupled surfaces supporting the theory of Nagoaka 
and others that PED adsorbs minimal numbers of platelets. It also indicates that 
the heparin surfaces have a slightly higher affinity for platelets than PED by 
itself, although the heparin surfaces adsorb significantly fewer platelets than any 
of the surfaces without PED or heparin. 
The conclusion that PED is an efficient surface for minimizing platelet 
retention is also valid with heparin immobilized to the PED chains. This is 
presumably due to the high flexibility of the PED chains on the surface which 
exclude platelets from interacting. Previous studies of the interactions of 
heparin and platelets are conflicting. The presence of heparin causes markedly 
greater platelet retention on glass bead columns. (144, 145) Heparin has been 
shown to independently induce and potentiate platelet aggregation and release 
reactions caused by exogenous agents; high molecular weight heparin fractions 
being more deleterious to platelet functions than low molecular weight fractions. 
Platelet interaction studies by Salzman et aZ. on a cellulose/ethylene 
imine/heparin surface demonstrated high degrees of platelet adhesion in 
vitro. (146) The authors concluded the adverse platelet interactions were due to 
increased fibrinogen ad sop rtion. If this result is true, then the PED/heparin 



















Mean Platelet Retention Index for Whole Blood 
and Platelet Rich Plasma 
Surface - Whole -p Blood P PAP 
Clean Quartz 1.00 1.00 
APS Quartz 0.86 0.83 
PEO- OCI 6,000 0.25 O. 27 
PEO- OCI 18,000 0.14 O. 21 
PEO-NCS 6,000 0.21 0.30 
PEO-NCS 18,000 0.19 O. 24 
PEO- OCI 6,000 O. 77 0.71 
PEO- OCI 18,000 .068 0.59 
PEO-NCS 6, 000 O. 72 O. 67 
PEO-NCS 18,000 0.65 0.61 
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There was little difference observed in the platelet retention index when 
the surfaces were exposed to either whole blood or platelet rich plasma. While 
the numbers of platelets retained by the surfaces in the presence of other blood 
components, i.e., whole blood, were considerably more (4.3 x 106 versus 3.2 x 106 
after one hour exposure time), this is not reflected when the data are normalized 
for the number of platelets in the whole blood or PRP before exposure. 
3.8 Platelet Factor 4 Release 
The adsorption of platelets does not necessarily correlate with their 
activation. Activation and degranulation of platelets were monitored in platelet 
rich plasma exposed to the heparin surface. Initially, 120 mg of beads of the 
PEO-bis chloroform ate were incubated for various lengths of time before 
measuring the PF4 release. The standard curve is shown in Fig. 48 and the 
sample results are shown in Fig. 49. In the period from 0 to 60 minutes exposure 
time, no difference in the PF4 plasma levels was observed. The PEO surfaces 
without heparin show slightly less PF4 released than the controls, but the heparin 
coupled surfaces were indistinguishable from the controls for each of the times 
tested. Very little difference (less than 10 percent) was seen between plasmas 
exposed for 5 minutes and those exposed for 60 minutes. 
The next set of experiments measured PF4 levels in plasma after 1 hour of 
exposure to differently derivatized beads. A standard curve was generated for 
each test. The results were normalized for the amount of heparin on the beads. 
No difference was noted in the PF4 levels between any of the derivatives or 
between the heparin coupled beads and the controls. The PEO surfaces without 
heparin again had only slightly less PF4 bound than either the controls or the 
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Figure 48. A typical standard curve generated during each series of the sample 


























Factor Four Release 
10 20 30 
Time of exposure ( min. ) 
.Clean Glass 
PEa· OCI 
PEO- OCI with 
heparin 
60 
Figure 49. Platelet Factor 4 levels in plasma exposed to derivatized beads for 





the PEO derivatized surfaces regardless of the time of incubation. The controls 
and the heparinized surfaces averaged approximately 23 .±. 0.9 ng/ml plasma. 
Relating these data to those of platelet retention reported in the previous 
section, some interesting facts emerge. The PEO surfaces without heparin 
retained significantly less platelets than either the controls or the PEO surfaces 
onto which heparin was immobilized. The fact that no difference is seen in the 
PF4 levels of the control and sample surfaces indicates that the adherent 
platelets on the PEO apparently are more highly activated to release their 
granule contents. Why this should occur is unclear. It may be that the 
sensitivity of the PF4 assay is not adequate to distinguish between small 
variations in low levels of PF4. Or the conclusion may be reached that while 
PEO surfaces do not permit much adsorption of platelets due to the reasons 
discussed above, those that do avoid the steric and entropic repulsion and reach 
the surface are activated by the immobilized PE~. Why this might happen is 
subject for speculation. 
CHAPTER 4 
DISCUSSION 
4.1 Poly(ethylene Oxide) Derivatization 
Poly(ethylene oxide) and its derivatives are widely used in various branches 
of industry. Replacement of the hydroxyl groups by primary amine groups has 
been reported by a variety of methods, some of which have minimal chain 
scission or branching problems. (147, 148, 149) The method reported here uses 
very mild conditions without the use of pyridine which has been reported to 
cause chain scission in the preparation of diamino PEO. (150) An 85 percent 
conversion of PEO to PEO-diamine ,was found by titration with perchloric acid 
and acetic acid anhydride. This produced a highly soluble, amine terminated 
polymer for reaction with phosgene. More direct routes have been reported for 
the isocyanate derivatization of PEO; however, this method was found to 
produce little chain branching, scission and a highly water soluble polymer. 
However, infrared spectroscopy showed the end product to be quite labile unless 
stored under nitrogen. This is one advantage of the method reported here. 
The coupling reaction to the primary amine of the APS coupling agent 
occurred readily for all the derivatives tested. The chloroformates appear to 
couple more readily but are slightly less stable once immobilized than the 
isocyanate derivatives. The difference in stability between the isocyanate and 
chloroformate terminated derivatives could possibly be due to the relative 
instability of the resulting urethane linkage when bonded to APS with respect to 
the urea linkages formed by the isocyanate and isothiocyanate derivatives. The 
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urea linkage is presumably stabilized in the aqueous solution by the resonance 
cation: 
+ 





This same linkage is involved in the immobilization of the heparin to the 
PEO isocyanate derivatives. These also were found to be more stable. 
The stability of these surfaces was monitored for three days. Longer term 
testing is necessary before this surface modification technique could become 
practical. However, a number of practical applications such as blood 
oxygenators and dialyzers could benefit from a protein resistant surface for even 
short times. 
A large number of factors are involved in the stability of a polymer grafted 
to a surface and im mersed into an aqueous salt medium. It is well known that 
aliphatic ethers react with oxidizing agents such as oxygen to form 
hydroperoxides which can degrade, generally by chain scission. (33) This reaction 
may be catalyzed by certain metals such as ferrous, copper and silver ions. 
Bailey, Callard and Lundberg, in an unpublished study, found that aqueous 
solutions of PEO undergo a rapid decrease in viscosity at pH 4 if the solutions 
are contacted with an iron rod. (121) 
Solutions of PEO are also sensitive to light exposure. (151) Significant 
decreases in viscosity due to ultraviolet light can be attributed to a free radical 
degradation mechanism. (152) In the immobilization reactions of this thesis, 
although the initial coupling reaction was carried out under nitrogen, no rigorous 
precautions were taken to exclude air and room light. The slides of the PBS 
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hydration study were handled using steel forceps which could have been a source 
of ions leading to chain degradation. Although the pH of the solution was 7.4, it 
may have caused chain scission. Even so, the XPS data indicate a surface rich in 
PEO, particularly for the 6,000 isocyanate and isothiocyanate derivatives. The 
greater stability of these derivatives would be expected over the higher 
molecular weight derivatives since the higher polymers are more susceptible to 
degradation. (152., 153) 
4.2. Protein Resistance of PEO Surfaces 
The four derivatives of PEO did not show significantly different abilities to 
resist protein adsorption (Table VI). This is not unexpected as there would be 
little difference in the surface seen by the proteins. The isocyanate derivatives 
are amine terminated and the chloroformate functionalities revert to hydroxyl 
groups after exposure to water. The small difference these end groups make in 
comparison to the long polymer chain is probably negligible. With no difference 
observed between the derivatives in terms of protein adsorption, it would then be 
beneficial to use the one providing the most stability; i.e., one of the isocyanate 
or isothiocyanate derivatives for further testing. 
An interesting point is the difference between the amount of protein 
adsorped by the chloroform ate derivatives of different molecular weight but not 
by the different molecular weight cyanate derivatives. A possible explanation 
for this might be the fact that the chloroformate surface has less PEO on the 
surface as exhibited by the 35 percent ether carbon content as compared to the 
45 percent for the cyanate derivatives. Although there was no difference in the 
surface coverage determined by the variable angle XPS data, the layer under the 
conditions of the XPS spectrometer is collapsed and condensed. The surface 
density of the grafted PEO under fully hydrated conditions may allow for much 
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greater flexibility of the less densely packed polymer surface. Why this is true 
for the chloroformate derivatives and not for the isocyanate or isothiocyanate 
derivatives remains unclear. Tanford found that the excluded volume of a 
surface decreases as the molecular crowding increases. (154) This is to say, 
there should be an optimal packing density of polymer chains on the surface to 
promote protein resistance. Nagaoka reports the surface mobility of grafted 
PEO chains is maximal when n, the number of repeat units is near 100. This 
translates to a molecular weight of approximately 4,500 (155). The protein 
resistance of a surface was found to be more effective if long chains with free 
ends were grafted to a surface rather than formed in a network or block system. 
The conditions in this study were optimized for maximum PEO coupling to 
the surface by varying the concentration of the PEO in solution. No attempt was 
made to determine the protein resistance of surfaces without the maximum 
amount of PEO coupled to them. O'ther than the TIRF studies in which a PEO of 
3,400 MW was used, no lower molecular weight PEO was tested for the protein 
resistance behavior. There would, of course, be advantages to using the lowest 
molecular weight PEO possible which still minimizes the protein adsorption. 
Lower molecular weight derivatives of the PEO are easier to synthesize and 
more efficiently coupled to the surface. Higher molecular weight polymers are 
more subject to chain scission and branching. From the results of the protein 
binding studies, it may be concluded that the 6,000 molecular weight derivatives 
do not adsorb sufficiently more protein as to necessitate using any longer chains. 
The amount of protein adsorbed by these PEO grafted surfaces is very 
similar to those reported by Nagaoka using methoxy poly(ethylene glycol) 
monomethacrylate with PEO side chains of various chain lengths. With n=100, 
the hydrogels synthesized by this group, with a water content of 45 percent, 
were found to have a 0.1 ug/cm2 which was considered to be negligible. (155) 
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Pekala and Merrill found that the surface of polyurethanes, with increasing 
molecular weight of the PEO block, consisted of at least 95 percent of the 
ethylene oxide of the PEO block. This surface, which is highly swollen with 
bound water, did not favor the adsorption of platelets. (156) The picture which 
emerges from this and other investigations is the extension of the PEO chains 
from the surface, whether those chains are incorporated into the network or 
grafted on the surface. The repUlsive forces which prohibit protein adsorption 
are generated by the loss of possible chain conformations as the volume available 
to the grafted chains is reduced due to the approaching species, i.e., the protein 
and polymer chains. 
The dynamic nature of protein adsorption to polymer surfaces has been 
investigated extensively. Reports using protein solutions show isotherms with 
monomolecular layer formation on the surface which fail to adsorb more protein 
with higher bulk protein concentration. However, in the long-term implants, 
multilayers are formed due to the rearrangement and exchange of protein by the 
surfaces. Adsorption must be considered a time dependent process. Matsuda has 
proposed a multilayer proteinaceous passivation mechanism for long term 
antithrombogenicity which requires up to Z weeks before hematological 
parameters return to normal levels. (157) However, in order for irreversible 
adsorption and adhesion to occur, blood components have to be in contact with 
the surface more than a certain measure of time. The rapid mobility of the 
hydrated PEO chains may prevent stagnation of the blood components on the 
surface because the contact time is too short. 
The protein concentration in plasma is quite high (approximately 8g/dl) 
compared to those used in the radiolabeled protein adsorption experiments. This 
gives a different physiochemical process for adsorption. In a highly concentrated 
system such as plasma, the PEO chains may find it thermodynamically favorable 
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to collapse. They may even be forced to "give up" some of their associated 
water due to osmotic increases. From indications in the whole blood clotting 
tests of this thesis, in which the PEO surfaces slightly increased the time to clot 
by a stagnant system, this seems unlikely. The surface is apparently still very 
hydrophilic and the PEO chains probably in the extended form. 
4.3 Heparin Immobilization 
Using a completely organic solvent system for the immobilization 
reactions, heparin was coupled to various chain lengths of two derivatized PEOs. 
The amount of heparin coupled to the surface was found to be a function of the 
molecular weight of the PEO, but not the type of derivative, i.e., the formation 
of a urethane linkage versus a urea linkage. The coupling presumably occurred 
through the free amines and hydroxyl groups present on the heparin molecule. 
Thus, by virtue of the method of attachment, the problems encountered when 
using the carboxylic groups for the site of attachment were avoided. Blockage 
of the carboxylic groups has been shown to cause loss of anticoagulant activity; 
however, free amines of heparin can be blocked with no loss in activity. (I18) 
Any reaction with the carboxylic groups of the heparin and the functional groups 
of the PEO would form unstable intermediates and would necessarily rearrange 
to couple with the free amines or the hydroxyls of the heparin. 
Another of the major benefits of this method of immobilization is that a 
totally organic solvent system prevents the possibility of inter- and intra-
molecular crosslinking of the heparin. This has been a problem encountered by 
other investigators requiring prior blockage of the carboxylic groups before 
immobilization, then reactivating them to produce maximum activity. The use 
of the pyridine catalyst in the reaction functions to increase the basicity of the 
hydroxyl groups rendering them more reactive. Merrill has proposed affixing the 
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heparin molecule by an end unit derived from the polypeptide serine and not by 
any of the side groups on the polysaccharide units (personal communication). 
Here again, the problem may be encountered requiring blockage of the 
carboxylic groups on the saccharide units. 
The amounts of heparin on the surface were found to be a function of the 
molecular weight of the PEO chains. The lower molecular weight derivatives 
coupled slightly more heparin than the higher molecular weight polymers. 
Higher yields of immobilized heparin may be attainable in different solvent 
systems; however, for the reasons stated above, aqueous systems would not be 
advisable. Heparin is virtually insoluble in most common organic solvents. In 
terms of amount of heparin per mg of beads, the 6,000 MW derivatives had 0.87 
ug heparin/mg and the 18,000 MW had 0.62 ug heparin/mg of beads. This 
compares to the immobilized heparin/agarose surfaces of Schmer containing five 
ug/mg of dry agarose when no spacer arm was used. Schmer also used a 
putrecine or -aminocaproy1- derivatized agarose to immobilize via the amine 
groups of heparin, and found much higher coupling efficiency, 60 ug/mg. 
Subsequently, the abilities of these surfaces to bind thrombin were also greater. 
It is difficult to compare amounts of heparin coupled to the results found by 
Ebert using derivatized Sepharose as they are expressed per mg of swollen 
beads. (118) However, Heyman, using similar methods of attachment, found 
amounts ranging from 1-4 ug/cm2. (119) 
The immobilized heparin was found to be stable after repeated washings 
with PBS, ethanol and methylene chloride as demonstrated by two techniques. 
First, using the sulfur ZP peak of the XPS spectrum, little loss was observed over 
the 3 day hydration period which was done prior to performing the activity 
assays (Table VIII). As can be seen in Fig. 41, the sulfur 2P peak of pure heparin 
powder occurs at approximately 162.5 ev binding energy and has an atomic 
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percent of 6.9 percent. The sulfur peak of heparin immobilized onto PEO-bis 
isothiocyanate (MW 6,000) is also seen in Fig. 41. It is quite easy to distinguish 
the sulfur from the thiocyanate as this is less electronegative and is not charge 
shifted, occurring at 158.5 eVe Since all the peaks and percentages are 
normalized for their Scofield cross sections and the number of scans, these data 
are directly comparable to those of Ebert, who monitored the 2S peak of 
immobilized heparin. (118) His pure heparin powder was found to have 5.3 
percent sulfur content. The sulfur of the immobilized heparins accounted for 
only 0.25 percent of the total surface signal. The surface of the PEO/heparin 
demonstrated 2.5 percent sulfur content, which is 10 times more than that found 
by Ebert. So although the amounts of heparin on the surface are not comparable 
directly by radiolabeling experiments, the XPS analysis suggests that the PEO 
coupled heparin surface contains a much higher percentage of heparin available 
for interactions. 
The second method to determine the stability of the immobilized heparin 
was to count successive washes of the labeled heparin beads which would 
indicate if heparin were leaching from the surface over time. Beads, which had 
been washed according to the final protocol developed prior to activity testing, 
had only 8.6 x 10-5 ug/cmZ• This amount slowly decreased to a final value of 9.Z 
x 10-6 ug/cm2 in the tenth and final wash. Even if the quantities of all the 
washes are added together, they total far less than the minimum amount of 
heparin required for thrombo-resistance. (115) This is also far less than would be 
required to produce the elevation in clotting times which were observed in the 
activity assays. 
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4.4 Blood and Protein Interactions 
Accomplishing the immobilization of heparin onto a surface is useless 
unless the activity of the heparin is established. With the stability of the heparin 
confirmed, the activities reported can be assumed to be a result of the 
immobilized heparin and not solution heparin which has leached from the 
surface. The results of the two clotting assays indicate significant increases in 
both the whole blood clotting time and the activated partial thromboplastin 
time. When comparing similar weights of beads, heparin coupled via the 18,000 
MW PEOs was slightly less active than those of the 6,000 MW derivatives. When 
this is normalized for the differences in amount of heparin coupled to the 
surfaces, no difference was found in the activity of the immobilized heparins. 
Still the activity of the heparin accounts for only approximately 24 percent of 
the native heparin if the equivalent amount were in solution. Although this is 
higher than some investigators have reported, (145) others have been able to 
retain a greater percentage of the native heparin activity. (119) 
The results of the platelet retention tests support the findings from other 
investigators. PEO is very efficient at minimizing platelet adhesion onto the 
surface and is still able to exert this influence even in the presence of the 
immobilized heparin. However, retention does not necessarily imply activation 
and release. Although controversial, soluble heparin has been shown to adversely 
interact with platelets, initiating aggregation and release of the contents of the 
~-granules. One of the substances released is Platelet Factor 4. PF4 has been 
shown to bind to heparin and inactivate it. 
The activation of the platelets which did adhere to the heparin derivatized 
surfaces were not statistically different from the controls as measured by the 
percentage of bound PF4. Although the PEO/heparin surfaces were found to 
retain fewer platelets, there was no difference in the PF4 levels between these 
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surfaces and the controls. This indicates that a fewer number of platelets 
produced the same amount of PF4. This same observation was made for the PEO 
surfaces in the absence of immobilized heparin. On the other hand, the heparin 
coupled surfaces, which in the absence of PEO would be expected to activate i'A-
granule release, showed no elevated levels of PF4 after exposure. This indicates 
that the immobilized heparin is not activating platelets as solution heparin has 
been reported to do. Presumably, this is due to the presence of the PEO chains. 
However, from the increase in clotting times obtained, the heparin is still 
capable of interacting with other coagulation factors. 
4.5 Summary and Conclusions 
The purpose of this dissertation, as stated in the introduction, was to 
investigate the properties of long poly(ethylene oxide) chains grafted to a 
surface in such a manner as to be capable of extension out from the surface. 
Due to the extension and the flexibility of the hydrophilic chains, an excluded 
volume is established, prohibiting other macromolecules from adsorbing to the 
surface. If this could be established, then the protein resistance of this surface 
could be utilized in conjunction with immobilized heparin. This would permit the 
extension of heparin out from the surface, mimicking solution activity towards 
particular coagulation factors. Optimally, the heparin activity could be 
maintained while still minimizing the nonspecific adsorption of proteins which 
otherwise could mask the heparin from further interactions. 
From these studies the following conclusions are made: 
1. By derivatizing various molecular weight poly(ethylene oxide} chains, 
highly reactive functional end groups may be formed which allow for straight 
forward coupling to free amines of an APS vapor-phase silanized surface. The 
reactions result in efficient transformation of the terminal hydroxyl groups to 
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chloroform ate, thiochloroformate, isocyante or isothiocyanate groups depending 
upon the reagents used. The PEO-bis chloroformate and PEO-bis 
thiochloroformate, not unexpectedly, were more highly reactive, resulting in 
more efficient coupling to the surface. It would be expected that any surface 
containing free amines would be capable of reacting with the functional end 
groups of the derivatized PEOs. This chemistry is suitable for PEO 
immobilization onto the surface of urethanes which could be used for numerous 
applications requiring mechanical strength not inherent to the PEO. 
2. The immobilized PEOs were characterized with respect to their 
stability in an aqueous salt medium and found to be stable over the period tested. 
The PEO-bis chloroformate and PEO-bis thiochloroformate have a higher degree 
of coupling to the surface than either the PEO-bis isocyanate or the PEO-bis 
isothiocyanate, but exhibit less stability in PBS solution. Presumably, this is due 
to the relative instability of the urethane linkage over the urea linkage, which 
possesses additional stability due to resonance of the adjacent double bonds. The 
thickness of the layer of polymer on the surface was investigated and no 
difference in thickness or degree of surface coverage was observed using 
variable angle XPS. It must be remembered that in the XPS spectrometer the 
chains would necessarily be collapsed and highly condensed due to the high 
vacuum. If the lengths of the fully extended chains are calculated from bond 
distances, the 6,000 MW and 18,000 MW PEO chains are 375 X and over 1000 ~ 
long, respectively. Using terminally bonded PEO chains on polystyrene latex 
particles dispersed in water, Cosgrove found that the segment density of PEO 
tails (MW 4,800) extended 30nm from the surface. (27) This is good evidence 
that the chains do extend fully into the solution. 
3. The method of attachment of the PEO chains, permitting extension out 
from the surface, is successful in excluding proteins from the surface. This was 
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demonstrated by the TIRF technique which monitors the protein bound to the 
surface in situ. The PED coupled surfaces were found to adsorb virtually no 
protein from two different concentrations of AT-m and from serum when 
adsorbed from flowing solutions. In the radiolabeled experiments, which 
necessitates that the protein be eluted from the surface, very little protein was 
detected in the wash. The 18,000 MW chloroformate surface was slightly more 
efficient at resisting adsorption than the 6,000 MW derivatives, but the same 
trend was not evident in the isocyanate derivatives. The reason for this 
discrepancy remains unclear. The chloroform ate derivatives were more resistant 
to protein adsorption than the isocyanate derivates when comparing equal 
molecular weights. This may be a function of the amount of PED coupled to the 
surface. The density of the isocyanate derivatives may have required tighter 
packing of the chains limiting the flexibility of the individual chains. 
4. The functional groups on the im mobilized PED were capable of binding 
to the hydroxyl and amine groups of heparin provided that they were not first 
exposed to atmospheric water vapor. This caused the hydrolysis of the 
functional end groups. The primary amines resulting from PED end group 
hydrolysis should have been capable of binding heparin via the carboxylic groups 
of the heparin molecule. Much less heparin was found on the surface when 
conditions permitted end group hydrolysis as demonstrated by the small sulfur ZP 
XPS peak. However, with reactive chlororformate and isocyanate groups, the 
immobilization of the heparin is quite straightforward. 
5. The immobilized heparin surfaces were characterized in terms of 
amount, stability and thickness of the layer. XPS data showed very little 
decrease in the total sulfur signal after the first hour of hydration in PBS buffer. 
This was confirmed by the radiolabeled heparin experiments designed to monitor 
leaching of the surface heparin. When the heparin surfaces were washed 
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adequately with distilled water, ethanol, and methylene chloride, no solution 
heparin was found in the subsequent water washes. The layer of immobilized 
heparin was found to cover approximately 95 percent of the surface although this 
represents the collapsed layer under vacuum conditions. The amount of heparin 
on the surface was found to be approximately 1.0 ug/cm2. with slightly less on 
the 18,000 MW PED surfaces. The reason for the decreased amount of heparin 
on the higher molecular weight polymer chains is unclear, but may be a result of 
using an organic solvent system for the immobilization reaction. The higher 
polymer may have been more highly coiled and therefore less accessible to the 
solution heparin. However, the organic solvent system used in this method of 
immobilization does not permit inter- and intramolecular crosslinking of the 
heparin molecules. 
6. The immobilized heparin is capable of binding AT-m as demonstrated in 
the TIRF and radiolabeled protein experiments. In the flowing solutions of the 
TIRF experiments, PED surfaces without heparin did not adsorb appreciable 
amounts of AT-m or other proteins from serum, but when heparin was coupled to 
the PED chains, some protein adsorption was observed. The TIRF experiments 
indicated that the heparin was not saturated in its ability to bind proteins. More 
AT-m was adsorbed when the solution concentration was doubled (twice that of 
physiological concentration) and from serum. The increase of the fluorescent 
signal resulting from serum adsorption, probably indicates other proteins were 
binding to the immobilized heparin. The amount of protein adsorbed by the 
immobilized heparin was still less than the control surfaces by nearly a factor of 
five. The ability of heparin to perform its anticoagulant function was 
demonstrated by the major increases in whole blood clotting and activated 
partial thromboplastin times. When normalizing to the weight of heparin on the 
surface, no difference between the different molecular weight spacers was noted 
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in the activity of the heparin as determined by APTT. Although the PEO and 
PEO/heparin surfaces demonstrated a significantly lower mean platelet retention 
index, there was no statistical difference observed between any of the surfaces, 
either between the surfaces with or without heparin and the controls in the 
amount of PF4 bound. This indicates that the platelets were activated to a 
greater degree by the PEO and the PEO/heparin surfaces, if the platelet 
retention experimental conditions can be assumed to produce similar results as 
those used in the PF4 assay. The PEO surfaces without heparin did not show any 
less PF4 than the controls or the heparinized surfaces. This is not corroborated 
by other investigators who report that PEO is inert towards platelets. Why this 
has been found in this study warrants further investigation. 
7. The activity of the immobilized heparin was shown not to be due to 
heparin released from the surface and in solution. This was demonstrated by 
monitoring the amount of radio1abe1ed heparin from the surface in successive 
washes of the surface. XPS monitoring of the heparin sulfur 2P peak 
demonstrated no loss from the surface during hydration over a 3-day time period. 
Also, heparin, which failed to clot whole blood after nearly an hour, was 
withdrawn and placed in a tube containing clean glass beads. All of the samples 
clotted within 9 minutes, indicating that no depletion of the coagulation factors 
had occurred. 
8. Even though the molecular weight of heparin ranges from 5,000 to 
30,000, the presence of this large molecule was s.hown not to mask the benefits 
of grafted PEO on the surface. Although, the APTT and PF4 levels were not 
quite as "good" as with PED chains without heparin, they were consistently 
better than the controls. 
I have demonstrated the feasibility of a PEO-heparin surface and some of 
the potential benefits in terms of protein and platelet compatibility. It is hoped 
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that, with further testing, long chain PEO can be grafted to a mechanically 
suitable polymer in such a manner as to permit attachment of heparin. If the 
grafting procedure allows for the extension of the PEO chains into solution, this 
surface should also minimize nonspecific protein adsorption. The in vivo results 
of such a device would have far ranging potential, if its efficiency could be 
established. 
4.6 Future Studies 
4.6.1 Derivatization of Graft Materials 
The ultimate test of the effect of PEO-heparin complexes must be on a 
mechanically suitable polymer. PEO, with terminal hydroxyl groups, offers a 
wide variety of methods to terminally graft the chains onto another polymer. 
The hydroxyl groups are easily replaced by other functionalities or may be used 
directly to couple to reactive groups on the polymer surface. The amines of 
urethanes offer an excellent opportunity for grafting PEO chains in a manner 
similar to those used in this dissertation. Diamino PEO could be esterified with 
alcohols in an acid catalyzed reaction to permit direct attachment to poly-amino 
acids. Aqueous irradiation may be used to graft PEO to crosslinked hydrogels. 
The extent of grafting to any substrate material must be studied on a case 
by case basis. If the PEO is crosslinked, the network chain density should be 
determined, and its effects on the extension of the chains into solution. The free 
PEO tails must then be available for the covalent attachment of heparin. Since 
heparin also possesses a number of functional groups, there are many varieties of 
possible mechanisms for its immobilization. 
The blood compatibility, protein adsorption and coagulation activation 
characteristics of these surfces would be an interesting extension of this study. 
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4.6.2 In-Vivo Characterization 
As mentioned previously, favorable in-vitro results do not necessarily 
correlate with in-vivo biocompatibility. Both acute and chronic 
thromboresistance of the PEO/heparin grafted surfaces must be tested in-vivo. 
The in-vivo stability of the surface is critical and should be studied. Cannulae 
with grafted PEO/heparin could be implanted and studied for the 
throm boresistance in both arterial and venous flow. 
4.6.3 Feasibility for Long Term Applications 
Any immobilized material, particularly a drug, is susceptible to enzymatic 
degradation. The long term potential of an immobilized heparin via PEO chains 
needs to be investigated. However, due to the degradation of the heparin, and 
the instability of the grafted PEO, long term applications may not be feasible. 
However, it may be that the presence of the PEO/heparin complex offers short 
term passivation which later may be replaced by inert proteineceous film 
deposits. ""'his phenomenon has been observed on long term artificial heart 
implants. (164) If the PEO/heparin can remain active until the hypercoaguability 
of the blood resulting from surgery returns to normal, the benefits are obvious. 
Also, there are anum ber of short term applications which could 
significantly benefit from a protein resistant surface. The left ventricular assist 
device (LV AD), currently being tested for short term (i.e., 2 weeks) use, offers 
an excellent surface which could benefit from an immobilized heparin surface 
which minimizes protein resistance. Blood oxygenators, used during open heart 
surgery, could be rendered much less detrimental to the blood, if the blood 
contacting surfaces had a grafted PEO/heparin complex on them. Certainly 
passivation of dialysis membranes might be achieved through this approach. The 
possibilities are numerous. 
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